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Glaucoma encompasses a group of conditions that result in damage to the optic nerve and 
can cause loss of vision and blindness. The nerve is damaged due to an increase in the eye’s 
internal (intraocular) pressure (IOP) above the nominal range of 15 – 20 mm Hg. There are many 
treatments available for this group of diseases depending on the complexity and stage of nerve 
degradation. In extreme cases where drugs or laser surgery do not create better conditions for the 
patient, ophthalmologists use glaucoma drainage devices to help alleviate the IOP. Many 
drainage implants have been developed over the years and are in use; but two popular implants 
are the Baerveldt Glaucoma Implant and the Ahmed Glaucoma Valve Implant. Baerveldt 
Implants are non-valved and provide low initial resistance to outflow of fluid, resulting in post-
operative complications such as hypotony, where the IOP drops below 5 mm of Hg. Ahmed 
Glaucoma Valve Implants are valved implants which initially restrict the amount of fluid flowing 
out of the eye. The long term success rates of Baerveldt Implants surpass those of Ahmed Valve 
Implants because of post-surgical issues; but Baerveldt Implants’ initial effectiveness is poor 
without proper flow restriction. This drives the need to develop new ways to improve the initial 
effectiveness of Baerveldt Implants. A possible solution proposed by our research team is to 
place an insert in the Baerveldt Implant tube of inner diameter 305 microns.  The insert must be 
designed to provide flow resistance for the early time frame [e.g., first 30 – 60 post-operative 
days] until sufficient scar tissue has formed on the implant. After that initial stage with the insert, 
the scar tissue will provide the necessary flow resistance to maintain the IOP above 5 mm Hg. 
The main objective of this project was to develop and validate an experimental apparatus 
to measure pressure drop across a Baerveldt Implant tube, with and without inserts. This setup 
will be used in the future to evaluate custom inserts and their effects on the pressure drop over 4 
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– 6 weeks. The design requirements were: simulate physiological conditions [flow rate between 
1.25 and 2.5 μl/min], evaluate small inner diameter tubes [50 and 75 μm] and annuli, and 
demonstrate reliability and repeatability. The current study was focused on benchmarking the 
experimental setup for the IOP range of 15 – 20 mm Hg. Repeated experiments have been 
conducted using distilled water with configurations [diameter of tube, insert diameter, lengths of 
insert and tube, and flow rate] that produce pressure variations which include the 15 – 20 mm Hg 
range. Two similar setups were assembled and evaluated for repeatability between the two. 
Experimental measurements of pressure drop were validated using theoretical calculations. 
Theory predicted a range of expected values by considering manufacturing and performance 
tolerances of the apparatus components: tube diameter, insert diameter, and the flow-rate and 
pressure [controlled by pump]. 
Benchmarking trials for Poiseuille flow used tubes [without inserts] that have inner 
diameters of 50 and 75 microns. The experimental data were within the theoretical range of 48.2 
– 103.2 mm Hg for 50 μm tubes and 9.2 – 16.8 mm Hg for 75 μm tubes for experiments run at 
2.5 μl/min. The two setups differed by about 1 mm Hg for a 15 mm Hg pressure drop [about 6%] 
in a 75 micron tube. Further benchmarking trials for annular flow were conducted using a 
standard size wire [diameter 0.270 mm] inserted in a syringe needle [inner diameter of 0.340 
mm]. The two pieces of apparatus produced results [with an average of 2.98 ± 0.32 mm Hg] 
which were within the theoretical pressure range [0.13 to 3.23 mm Hg] and had a difference of 
about 0.5 – 1 mm Hg in the measured pressures. Trials were also conducted with different types 
of sutures placed in the implant tubes to form annular flow. The following suture properties were 
varied: absorbable/non-absorbable, flow rates [1.5 and 2.5 μl/min], lengths [4 and 8 mm] and 
diameters [0.15, 0.2, and 0.3 mm]. The results from these trials indicated that the pressure 
profiles of absorbable sutures increase over time [from 3 to 5 mm Hg], probably because the 
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sutures expand as they become hydrolyzed. However, the pressure profiles for non-absorbable 
sutures demonstrated a steady pressure [from 0.5 to 1.5 mm Hg]. Hence, the two setups can be 
used to verify the pressure responses of different types of inserts when they are placed within 
tubes of dimensions similar to those of Baerveldt Implant tubes. It is recommended that trials be 
conducted with different needle and wire combinations to generate a good data base to further 
benchmark the annular flow. 
In addition, preliminary experiments evaluated the dissolution of suture samples in a 
balanced salt solution and in distilled water. The balanced salt solution approximates the eye’s 
aqueous humor properties, and it was expected that the salt and acid would help to hydrolyze 
sutures much faster than distilled water. Suture samples in a balanced salt solution showed signs 
of deterioration [flaking] within 23 days, and distilled water samples showed only slight signs of 
deterioration after about 30 days. These preliminary studies indicate that future dissolution and 
flow experiments should be conducted using the balanced salt solution. Also, the absorbable 
sutures showed signs of bulk erosion/deterioration in a balanced salt solution after 14 days, 
which indicates that they may not be suitable as inserts in the implant tubes because flakes could 
block the tube entrance. Further long term studies should be performed in order to understand the 
effects of constant fluid movement over the surfaces of the absorbable sutures, by better means 
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AX Area of cross-section at Section X of the experimental setup, where X can refer to 
tube [t], catheter hub [CH], needle hub [NH], or PEEKsil tube [p] [m2] 
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D  Inner diameter of tubing [m] 
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[m of water] 
hmx Minor loss due to expansion or contraction in Section X of experimental setup, 
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hdiff  Head loss due to elevation [m] 
IOP   Intraocular pressure [mm Hg] 
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r  Coordinate in the radial direction [m] 
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r1   Outer radius of the insert [m] 
r2   Inner radius of the tube [m] 
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Chapter 1: Introduction 
1.1 Overview 
This chapter reviews the objectives of this thesis. The second chapter introduces the 
disease glaucoma: different types, the causes, and various treatment procedures available. Then 
implant selection is covered, and a comparison between the two most commonly used implants is 
given. The theory behind the flow through tubes and a general overview of the different types of 
sutures is also discussed. The third chapter goes into the components used to make the setup, 
benchmarking trials for the setup, residual pressure trials, and the trial matrix. The fourth chapter 
contains a discussion of the results from the short term flow trials that were conducted. The fifth 
chapter discusses the results from the long term flow trials, and suture deterioration trials. The 
sixth chapter goes over the conclusions and recommendations for future study.  
Medical terminology for several common medical terms is provided in Appendix A. 
Appendix B lists the major components in the experimental setups. Appendix C lists the 
important PneuWave pump specifications. Appendix D enumerates the steps that need to be 
followed when using the PneuWave pump software. Appendix E has the basic specifications of 
the Omega pressure transducer installed in the experimental setup. Appendix F shows the 
process to be followed to log data using Omega data logging software. Appendix G gives the 
general specifications of the Omega data logger. The calibration curve used to convert the 
millivolt readings from the data logger to pressure readings is given in Appendix H. Appendix I 
shows the theoretical pressure calculation for a standard tube, annulus, and annulus with 
eccentricity. Appendix J enumerates the procedure used to calculate the overall theoretical 
pressure drop for all of the benchmarking trials. Appendix K lists the procedure to be followed 





Glaucoma is a very common eye disease that is treated with medications or with surgical 
implantation of tube shunts, such as the Ahmed Glaucoma Valve Implant or the Baerveldt 
Glaucoma Implant, depending on the amount of damage to the optic nerve in the eye [1-5]. The 
overall aim of this study is to research how to improve the initial effectiveness of Baerveldt 
Glaucoma Implants by eliminating hypotony in the early post-operative period. A method for 
improvement is to increase the flow resistance on a temporary basis [say 30 – 60 days] which 
could resolve some of the early post-surgical issues associated with the implant. These issues and 
their implications are explained in detail in Chapter 2. Different methods to increase the flow 
resistance temporarily are analyzed. These methods are simple modifications performed by 
doctors during surgery such as internal tube occlusion [stent], external tube occlusion [ligature], 
and two stage procedures [5]. However, this thesis is focused on determining if inserts of a 
specific size and type would help to achieve this objective. In order to test the inserts, an 
experimental flow apparatus was designed in order to collect repeatable and accurate pressure 
data at low flow rates [1.25 – 10 μl/min]. This thesis covers the initial stage of the research. 
Keeping this in mind, the main objectives of this research were as follows: 
 Develop a reliable experimental apparatus to measure pressures in the range of 0 – 50 
mm Hg, in tubes and annuli of less than 300 micron diameter, and at flow rates of 1 – 10 
μl/min. 
 Benchmark the setup for selected sets of tube and flow configurations. 
 Determine the amount of pressure increase in the system when various suture strips are 
inserted into the Baerveldt Implant tube, and determine when or if the pressure returns to 
levels similar to there being no sutures in the tube. 
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 Evaluate the swelling and deterioration rates of absorbable sutures in distilled water and a 
balanced salt solution. 
 Evaluate the increase in pressure when different suture materials [absorbable and non-
absorbable] are inserted into the implant tubing. Also evaluate which suture material 
works best, and what characteristics of the suture [diameter, length, type and 
composition] impact the pressure increase. 
The strategic aim is to be able to develop a method to improve the effectiveness of Baerveldt 





Chapter 2: A Brief Introduction to Glaucoma and Treatment, and 
Fluid Flow Theory  
2.1 What is Glaucoma? 
Glaucoma is a term inclusive of many different conditions that have a common result of 
optic nerve damage related to elevated intraocular pressures [IOP] [3, 6]. If left untreated, the 
pressure-related optic nerve damage can be progressive and result in partial or complete loss of 
vision. Normally, the IOP is between 8 – 21 mm of Hg [7]. In a study conducted in 1958, 
Leydhecker [7] measured the eye pressures of 10,000 people with no known eye disease; the 
resulting distribution of IOP resembled a Gaussian curve centered at 15 mm of Hg [± 2.5 mm 
Hg]. A healthy IOP is a result of the equilibrium between the amount of aqueous humor being 
produced within the eye and the physiologic outflow of the fluid from the eye [8]. Aqueous 
humor is a fluid produced in the eye, rich in nutrients and electrolytes, to nourish all the parts of 
the eye. In most cases, aqueous humor production rates are constant, within a range of 1.5 – 2.5 
μl/min, which implies that elevated IOPs are a result of increased resistance to the outflow of 
fluid [9, 10]. For elevated IOPs, the flow rate can drop to about 1 μl/min, but the aqueous humor 
production does not stop permanently [10]. Refer to Appendix A for a glossary of medical terms 
used in this thesis. 
2.2 Types of Glaucoma 
There are many types of glaucoma, such as neovascular, traumatic and pseudoexfoliative 
[3], some of which are very rare as compared to the following types. 
2.2.1 Open-angle glaucoma [wide-angle glaucoma] 
The most common type of glaucoma is open-angle glaucoma or wide-angle glaucoma 
[1]. The configuration of a normal eye does not have any obstructions to the ‘angle’ [Fig.1]. For 
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an eye with open-angle glaucoma, the trabecular meshwork gets “clogged”, due to various 
factors, and the angle between the iris and posterior surface of the eye remains unchanged. 
 
Figure 1: Open-angle glaucoma [reproduced from Ref. 1] 
2.2.2 Angle-closure glaucoma  
Another type is acute or chronic angle-closure or narrow-angle glaucoma. This is less 
common than open-angle glaucoma but is usually characterized by an acute increase in the IOP 
[1]. The angle between the iris and the posterior chamber of the eye is narrowed by the 
configuration of the internal eye anatomy [Fig. 2]. The drainage channels become occluded by 
the iris and the surrounding structures, resulting in a sudden and sharp increase in IOP.  
  




2.2.3 Normal-tension glaucoma  
Normal-tension glaucoma is also called low-tension or normal pressure glaucoma. In this 
condition, the angle between the iris and posterior chamber is normal, and the IOP is in the 
normal range [1]. However, there is damage to the optic nerve that has the characteristics typical 
of an eye affected with open-angle glaucoma but without the elevated IOP. The reason is thought 
to be related to some internal weakness or dysfunction in the optic nerve [1].  
2.2.4 Congenital glaucoma 
This type of glaucoma usually occurs in newborns in conjunction with incomplete 
development of the eye’s drainage canal during the prenatal period. This is a very rare condition 
that occurs in 1 out of every 10,000 births. This is a common term used for glaucoma diagnosed 
in infancy or early childhood [1, 3]. 
2.2.5 Other types of glaucoma 
Other variants of open-angle and angle-closure glaucoma include [1]: 
 Secondary glaucoma 
 Pigmentary glaucoma 
 Pseudoexfoliative glaucoma 
 Traumatic glaucoma 
 Neovascular glaucoma 
 Irido Corneal Endothelial Syndrome (ICE) 
These types are variations of open-angle or angle-closure glaucoma which can be caused due to 
small inflammation or injury of the eye. They can occur in either one eye or both eyes. These are 
very rare, and less than 10% of Americans [approximately] with glaucoma have one of these 




IOP is a result of the equilibrium between the production of aqueous humor in the eye 
and subsequent outflow from the eye through drainage canals. The aqueous humor is produced in 
the ciliary body of the eye at a nominal rate of about 2.5 μl/min [though the flow rate ranges 
between 1.5 – 2.5 μl/min for the average person, depending on various factors] and circulates 
around structures in the anterior part of the eye in order to provide nutrition and oxygenation to 
clear structures which lack blood vessels [2, 4]. The aqueous humor then exits the eye through 
the drainage canals to be recycled within the blood stream [4]. The normal production of aqueous 
humor is relatively constant. As a result, the IOP becomes a function of resistance to outflow 
through the drainage canals. Improper circulation/drainage of aqueous humor can result in 
increased IOP. This fluid flows out of the eye through a mesh-like channel, called the trabecular 
meshwork, into Schlemm’s canal [refer to Fig. 3] [11]. If the canal becomes blocked, for reasons 
unknown at this time, fluid builds up in the eye and cannot filter out at the usual rate, resulting in 
an increased IOP. This condition has been observed to be hereditary and limited to certain ethnic 
groups of a particular age group [5]. Glaucoma can occur in both eyes, but the extent of damage 
in each eye may not be the same [12]. 
In the case of open-angle glaucoma, the angle formed between the iris and the cornea is 
wide; but since Schlemm’s canal is partially blocked, it causes the outflow rate of the aqueous 
humor from within the eye to drop. This in turn results in an increase in IOP [3]. The damage 
caused by the increase in IOP does not induce significant pain or show any symptoms until much 
later, say a few months [2]. The damage to the optic nerve occurs slowly; but one may lose an 




Figure 3: Flow path of aqueous humor [reproduced from Ref. 11] 
Angle-closure glaucoma occurs when the IOP increases. The iris bulges out causing the 
angle between the iris and the cornea to narrow. As a result, the aqueous humor will not be able 
to drain out, causing the IOP to increase even more [1]. Angle-closure glaucoma usually occurs 
abruptly but can also occur gradually. If one has a narrow drainage angle, sudden dilation of the 
pupils can trigger acute angle-closure glaucoma [1]. 
2.4 Treatment 
Although glaucoma cannot be completely cured and any optic nerve damage is 
irreversible, the main goal of treatment procedures adopted by doctors is to help reduce the IOP. 
The treatment is concentrated on curbing further damage to the optic nerve [5]. There are many 
treatments administered to patients depending upon the stage of the disease. Initial therapy 
usually consists of administration of eye drops, and/or oral medication. These medications help 
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lower the IOP by decreasing the amount of aqueous humor produced [1]. If the administration of 
medications is insufficient to lower the IOP to a safe level for the optic nerve, then treatment 
progresses to laser or surgical therapy. Laser treatment, filtering surgery and/or drainage 
implants are proposed based on the complexity of the disease or extent of damage; and the 
potential responsiveness of the patient to the treatment [most patients fall in the age group of 60 
years and above]. Laser treatment is performed to clear the blockage in the drainage canal [4]. 
Initially the IOP is well within the normal range; but as time progresses, the IOP tends to 
increase again. Drainage implants are used only when the patient is at an advanced stage of 
glaucoma or has secondary glaucoma [3, 9].  In surgical therapy, alternate outflow pathways for 
the aqueous humor are established either by creating a fistula [or hole] from inside the eye to the 
exterior or by implanting a tube shunt, such as a Baerveldt Glaucoma Implant or Ahmed 
Glaucoma Valve Implant, to drain the aqueous humor from the anterior chamber to the exterior 
of the eye ball [5]. 
The drainage devices [or aqueous shunts] are designed to create an alternate path for the 
aqueous humor to flow as needed from the anterior chamber of the eye to the exterior of the eye. 
All implants are designed to reduce the IOP by restoring the outflow of the aqueous humor to the 
normal flow rate, regardless of the implant type [3, 5]. These drainage devices have good success 
in controlling the IOP as compared to other surgical methods. The first implant to be tested was 
the Molteno Implant in 1969 [1, 5, 8] shown in Fig. 4. There have been significant developments 
in the basic design over the past 40 years; and this has led to lower post-surgery complications. 
Some drainage devices have been developed that offer special features to improve IOP, reduce 
acute postoperative hypotony, and facilitate implantation [5]. 
Drainage devices come in different configurations, materials, etc., some with regulating 
valves [Molteno, Fig. 4; Ahmed Glaucoma Valve, Fig. 5; Shocket, and Eagle vision implants] or 
10 
 
without [Baerveldt [13] [14], Fig. 6]. The regulating valves are used to restrict the flow and to 
allow unidirectional flow of aqueous humor from the anterior chamber to the exterior channels. 
The valves are used until the scar tissue grows over the implant, increasing the flow resistance. 
These implants are reserved for patients with very severe uncontrolled glaucoma and for those 
who have failed to respond to other techniques/surgeries [12]. 
 
Figure 4: Molteno Implant [reproduced from Ref. 5] 
 
 





Figure 6: Baerveldt Glaucoma Implant [reproduced from Ref. 14] 
2.5 Selection of the Appropriate Implant 
There are many factors that influence the decision of the surgeon when selecting the type 
of implant for the patient.  
One of the factors is IOP control. It is easy to control the IOP in the early postoperative 
stage when devices such as the Ahmed Glaucoma Valve or Molteno Implant are used because of 
the flow restriction that the valves produce. Such implants are always preferred for patients with 
poor compliance to the medication and hence requires very few follow-up visits post-surgery [5].  
Another factor that influences the decision is the growth rate of scar tissue on the implant. 
The rate of growth helps determine the type and size of implant [Fig. 7]. However, the most 




Figure 7: Baerveldt Glaucoma Implant in the eye [reproduced from Ref. 4] 
Early post-surgery IOPs are controlled by the resistance to flow offered by valved or non-
valved implants. Because of the increased resistance to flow, valved implants offer more chances 
to control IOP and have lower probability of causing hypotony. As a defense mechanism against 
any foreign material implanted in the body, scar tissue begins to cover the implant and forms a 
permeable casing over the implant. The scar tissue growth depends on the patient’s age and 
metabolism, but typically occurs within 30 – 60 days [4]. 
For the non-valved devices, doctors usually tie down/sew the tubes partially closed to 
offer some resistance until the scar tissue grows sufficiently. This method adopted by doctors is 
one of the reasons why the postoperative IOP can be controlled for non-valved implants [5]. 
Studies have shown that the surface area of the implant and thickness of the scar tissue growth 
on the implant play an important role in having better control of IOP in the long run. The growth 
of the scar tissue in turn controls the percolation of the aqueous humor [15].  
  





2.6 Possible Post-Surgical Complications 
Usually, some form of flow restriction [e.g., tying sutures] is implemented so that 
aqueous humor does not flow out of the anterior chamber uncontrollably, which would cause a 
drastic drop in IOP in the eye. This is the main reason why Baerveldt Implants might not be 
preferred, though their long term performance is much better than valved implants [covered in 
Section 2.7] like Ahmed Valve Implants [5, 16]. In the long run, when the scar tissue develops 
over the implant, the resistance to flow increases, and there is no need for valves or any other 
form of flow restriction to maintain the IOP above 5 mm of Hg.  
2.7 Ahmed Glaucoma Valve Implant vs. Baerveldt Glaucoma Implant – A 
Comparison 
Drainage devices with open tubes are more likely to cause complications such as early 
postoperative hypotony, and hence the tubes should be temporarily closed using stents or 
ligatures [1]. The research interest of this thesis is focused on Baerveldt Glaucoma Implants 
because they have shown better success rates than Ahmed Implants in the long run [17]. The 
central idea of this work is to develop a technique by which the existing Baerveldt Implants 
could be modified easily and in a safe manner to avoid early postoperative hypotony.  
Based on five year treatment outcomes in an Ahmed and Baerveldt comparison study 
[17], it was determined that there are similar rates of long-term surgical success for both 
implants. However, the Baerveldt Glaucoma Implant showed a greater reduction in the IOP [12.7 
± 4.5 mm Hg for the Baerveldt Glaucoma Implant against 14.7 ± 4.4 mm Hg for the Ahmed 
Glaucoma Valve] and a lower rate of reoperation than that of the Ahmed Glaucoma Valve 
Implant, although the Baerveldt Glaucoma Implant showed twice as many failures because of 
safety issues like hypotony, implant ex-plantation [removal of implants after surgery] and loss of 
light perception [low vision/blindness]. The reasons for treatment failure were different for the 
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Ahmed Glaucoma Valve Implant: a higher IOP range, even though the Ahmed Glaucoma Valve 
controlled IOP to a greater extent in the early postoperative period as compared with the 
Baerveldt Glaucoma Implant. The point that a Baerveldt Glaucoma Implant yields two mm of 
Hg lower IOP than the Ahmed Valve [17] must be weighed against the larger number of safety 
end points [higher rate of hypotony] in the Baerveldt Implant study group when compared with 
the Ahmed Glaucoma Valve. 
From a comparison study of the design, baseline patient characteristics and intraoperative 
complications [18], it was noted that both devices had similar baseline characteristics; and there 
were a similar number of intraoperative complications for both devices.  
On long term follow-ups in which ‘success’ was defined as a low-end cutoff of about 5 – 
6 mm of Hg and a high end of 21 – 22 mm of Hg with or without medication, Baerveldt 
Glaucoma Implants shared a success rate of about 93% and 88% for 350-mm2 and 500-mm2 
implants, respectively, after 18 months [19].  
2.8 Theory 
In order to be able to validate the experimental setup, some basic flow concepts are 
needed to predict the pressure created by a set of flow parameters. The following theoretical 
concepts were used to model the pressure drop for normal flow and annular flow through a tube 
having a concentric annulus. 
2.8.1 Flow through tube – Poiseuille’s flow 
The concept of Poiseuille’s flow [20] was used to model pressure drop for flow through 
small diameter tubes, in order to benchmark the setup. The operating flow rate range for this 
application is in microliters per min [1.5 – 2.5 μl/min]. Steady, fully-developed, axisymmetric, 
laminar flow of an incompressible, Newtonian fluid allows the use of Poiseuille’s law [20, 21].  
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∆𝑃 =  
8 𝜇𝐿𝑡𝑄
𝜋𝑟2
4            (1) 
where, 
ΔP   Pressure drop [mm Hg or Pa] 
μ   Dynamic viscosity of fluid [Newtonian fluid] [Pa.s] 
Lt   Length of tube [m] 
Q   Flow rate of fluid [m3/s] 
r2   Inner radius of the tube [m] 
The boundary conditions used for deriving this equation are: no-slip at the tube surface [r=r2], 
and an axisymmetric flow profile which sets the rate of change of the velocity at the center of the 
tube [r=0] to zero. 
2.8.2 Flow through annulus – Poiseuille’s flow 
A modified version of Poiseuille’s equation [22], considering flow through an annulus, 
was used to develop a better understanding of the flow profile when there is flow between 
concentric tubes. As seen in Fig. 8, frictional effects occur on both surfaces: the inside of the 
outer tube and the outside of the inner tube. 
The equation for such a situation can be derived with the same assumptions as used for Eq. (1), 
but with different boundary conditions: no-slip conditions on the outer surface of the inner tube 



































       (2) 
where, 
Q   Flow rate of fluid [m3/s] 
ΔP   Pressure drop [Pa or mm Hg] 
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μ   Dynamic viscosity of fluid [Pa.s] 
Lt   Length of tube [m] 
r1   Outer radius of inner tube/insert [m] 
r2   Inner radius of outer tube [m] 
 
Figure 8: Flow between two concentric tubes [reproduced from Ref. 22] 
Note that, as r1  0, Eq. (2) goes to Eq. (1). 
2.9 Sutures – Types and Background 
There are basically two types of surgical sutures [25, 26]: absorbable/degradable and 
non-absorbable/non-degradable. As the names suggest, the first type dissolves over time when 
exposed to liquid such as water or saline solution, and the latter does not dissolve. For example, 
in the case of a monofilament [Monocryl] suture in surgical settings, the dissolution takes 
approximately two weeks to begin [27]. At that time, the tensile strength of the suture starts to 
deteriorate [27]. Absorption rates vary and can be affected by patient health. For instance, having 
a fever, infection, or protein deficiency can increase the absorption rates [25]. There are different 
materials which are used to make absorbable and non-absorbable types of sutures. Some 
materials used to make absorbable sutures are polyglactin 910, poliglecaprone 25 and 
polydioxanone [26]. Materials such as polyester, nylon, silk, polypropelene and sometimes 316L 
stainless steel, are used to make non-absorbable sutures [27]. In addition, it is thought that non-
braided sutures cause less reactivity in the body and are not as prone to becoming infected 
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because they lack the grooves and rough surfaces to which molecules/bacteria may adhere [25]. 
Plain catgut and chromic catgut are variations of absorbable sutures that have very low tensile 
strength and deteriorate much faster [within 7 – 10 days of surgery] than the other absorbable 
sutures [26]. However non-braided sutures may have a greater tendency to loosen at the surgical 
knot due to there being less ‘grip’ [26]. Figure 9 shows examples of some of the different types 
of sutures.  
The absorbable sutures are of interest because, when they are inserted in BGI tubing and 
begin to deteriorate over time, they could provide the much needed initial flow resistance. Then, 
later, these sutures would disappear; and the flow resistance would be due to scar tissue on the 
plate of the BGI. Hence, a part of the study analyzed the different sutures and how they 
deteriorated, and checked to see if the ‘resistance to flow’ initially increased in order to maintain 
clinically relevant pressures [around 15 mm Hg]. The results from these trials are discussed in 
detail in Chapter 5.  
 
Figure 9: Different types of sutures [reproduced from Ref. 25] 
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Chapter 3: Development and Validation of the Experimental 
Apparatus 
3.1 Overview of Apparatus 
The experimental setup was developed based on a preliminary concept provided by Dr. 
Paul Munden, ophthalmologist at the KU Eye Clinic. The setup must be able to pump fluid at a 
constant rate of 1 – 10 µl/min, with 2.5 µl/min being preferred, the typical flow rate of aqueous 
humor in a normal human eye; measure the differential pressure in the system when an insert is 
placed in the BGI tube; and record the flow and pressure trends over a set period of time. The 
term “system” refers to the setup, and the term “tube” refers to the BGI tubing that is attached to 
the setup. The flow rate for these experiments was very low; hence a peristaltic or syringe pump 
was envisioned. But since these experiments ran over long periods of time, between 24 hours and 
approximately 20 days, a PneuWave pump [28] was purchased. The PneuWave pump comes 
with a flow sensor that measures the low flow rate precisely [1 – 50 µl/min, ±5% of set point 
value]. Also, the pump has the capability to accommodate a bigger reservoir, say 500 ml, than 
most pumps that handle such low flow rates, in order to enable smooth long term trials without 
the need to refill/replace the fluid in the reservoir.  
A schematic of the overall experimental setup is shown in Fig. 10. The setup consists of a 
500 ml bottle, the PneuWave pump, and a pressure transducer and data logger [Omega] that are 
connected to a computer in order to record and retrieve data. A trough is placed at the outlet in 





Figure 10: Schematic of experimental setup showing all major components 
Figures 11 and 12 show the actual setups as assembled in LEA 3127 of Learned Hall, 
Mechanical Engineering. Two nearly identical setups were used, which helped to perform twice 
the number of trials for speedier data collection. For the same input parameters, the results and 
operation of both the setups were compared. Appendix B details the pieces of equipment in both 
setups. 
 







Figure 12: Assembled experimental Setup #2 
3.2 Components in the Setup 
3.2.1 Pump 
The PneuWave pump [28] is a high-precision [within ±5% of set point flow rate], closed 
loop, programmable, pulse-free pump that best fits this microfluidic application as outlined in the 
following discussion. A block diagram of the PneuWave pump is shown in Fig. 13. Refer to 
Appendix C for the pump’s specifications. Appendix D enumerates the steps followed in order 
to operate the pump using the ‘PneuWave’ software tool. 
The pump consists of a pressure regulation system and a flow sensor which are in 
constant communication with a microprocessor. The pump pressurizes an easy-to-access fluid 
vessel which can range in volume from a few microliters to greater than a liter. The vessel is 
pressurized with a quiet, integrated, miniature pressure regulation system [28]. Once the vessel is 
pressurized, fluid moves through the tubing. An in-line flow sensor measures the actual 
displacement or flow rate. When operated in flow-control mode, both the flow sensor and the 
compressor regulation system are in continuous communication with the microprocessor. Based 
on the flow sensor readings, the microprocessor sends commands to the compressor regulation 
system, allowing for highly precise [within ±5% of set point value] flow control with micro-liter 





achieved. Alternatively the PneuWave pump can be operated in pressure-control mode where the 
compressor regulation system is set at a user-defined pressure value [0 – 12 psi or 0 – 620.4 mm 
Hg], and adjustments based on flow sensor readings are not made. 
 
Figure 13: Block diagram of PneuWave pump, including a fluid reservoir bottle [reproduced 
from Ref. 25] 
The flow rate is measured using a thermal propagation wave that is detected by RTDs 
placed around the tubing. A heater filament emits a thermal signal, depending on the set 
point/target value, and the RTDs measure the temperature on both sides of the tube and compare 
these temperatures [28]. If the temperature measured on one side is lower or higher than the 
filament’s temperature, the micro-regulator in the pump activates or deactivates the air pressure 
control (air compressor). This method of flow rate measurement eliminates physical contact of 
any mechanical/moving parts with the fluid. The pump was specifically designed by the vendor 
for this application wherein a 500 ml bottle can be used to run long term trials [up to 60 days] 
without the need to refill the bottle or disturb the setup. A custom program was developed by the 
vendor to allow control of the data capture rate [0.1 – 10 second intervals], the length of each 
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trial [whatever duration is required from a few minutes to 60 days] and the mode used [either 
flow-control or pressure-control].   
3.2.2 Pressure transducer and data logger 
The Omega pressure transducer chosen for this application has a 0 – 2.5 ± 0.2 psi range 
[0 – 130 ± 10.5 mm Hg; see Appendix E] [29]. The piezo-resistive process uses strain gages 
molecularly embedded into a highly stable silicon wafer. The silicon wafer is divided into 
individual dies, each of which contains a full strain gage bridge. Each die is mounted in a sealed 
chamber protected from the environment by glass-to-metal seals and a stainless steel diaphragm. 
A small volume of silicone oil transfers the pressure from the diaphragm to the strain gage 
bridge. The construction provides an accuracy of ± 0.08% of best fit straight line and stability, 
and minimal thermal effects [refer to Appendix E for the specifications and to Appendix F for 
the operating procedure]. This design provides secondary fluid containment in the event of a 
diaphragm rupture.  
The Omega transducer is connected to an independent data logging device [refer to 
Appendix G for specifications] [30], which can be accessed using OMEGA software to 
start/stop data logging and download data from the logger. A constant DC power source [5 – 10 
V, see Appendix B] supplies power to the transducer. The output from the transducer is in 
millivolts and can be converted to psi using the calibration curve/equation provided with the 
transducer [refer to Appendix H for the calibration data]. The end of the transducer that 
measures the pressure is connected to the setup using a simple rubber-tube connector. There 
were leaks when the rubber-tube connector was used. Hence, in order to stop the leaks, the 
connection was completely covered with caulk and super glue [refer to Fig. 14]. After letting the 
caulk and super glue dry, repeated trials were conducted, at high pump pressures [10 – 12 psi], to 
ensure that the seal held. This was verified by checking for leaks when trials were conducted at 
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these high pump pressures, by temporarily closing the three-way valve causing the pressure at 
the transducer to build up to about 100 mm Hg. Once the pressure reached 100 mm Hg at the 
transducer, and no leaks could be detected on the seal, it was confirmed that there were no leaks 
in the setup.  
3.2.3 Connectors and other items 
The air-pressurized bottle [refer to Appendix B] was filled to its maximum level [500 ml 
mark on the bottle] with distilled water, leaving space for pressurizing the air. The pump was 
placed on foam pads [refer to Fig. 12] so that vibration from its air compressor did not affect the 
experimental setup. The rest of the setup was placed on a wooden board [refer to Fig. 12], 
elevated to about five inches above the water level at the pump outlet. The setup was initially 
placed lower than the pump outlet, and problems were experienced because of backflow and/or 
no outflow of fluid [refer to Fig. 12]. For this reason, the wooden boards were used to raise the 
setup to a height of about five inches above pump outlet. The wooden boards and foam pads 
were used to make a sturdy base for the setup, not affected by vibration which might be 
transmitted through the table on which the setup was placed.  
Medical grade tubes were used to form a simple connection between the pump and the 20 
gauge cannula. The pump was connected to the rest of the setup using a PTFE 
[polytetrafluoroethylene] connection tube, provided by the pump vendor. The PTFE tubes 
provided for the two setups were different lengths. The tubes were connected in a way so that 
one setup had the longer tube and the other had the shorter tube. A three-way valve [refer to Fig. 
14] was used to connect the pressure transducer’s tubing to the rest of the setup. The remaining 
portion of the setup had a 20 gauge cannula with a BGI tube [ID 0.305 mm] inserted in the 
cannula. The implant tube was glued in place using cyanoacrylate [discussed in Section 3.3]. A 
small trough was used to collect the water exiting the setup. The trough had 10 sub-troughs, most 
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of which were not filled with water. This was done to allow the excess water collecting in the 
sub-trough, with the outlet in it, to spill over to the neighboring sub-troughs, thereby avoiding 
disturbances in the readings by maintaining the water level above the outlet.  
The 500 ml glass bottle was autoclaved before starting the trials in order to ensure that no 
bacteria were present. For about a month, the trials were run with a balanced salt solution [98.5% 
distilled water + 1.5% salt]; but over time, it was discovered that the salt solution became a 
breeding ground for bacteria and fungi. This finding led to the replacement of the salt solution 
with distilled water [from October of 2014] so as to ensure clean trials. The bottle was 
autoclaved again before using distilled water. 
 
Figure 14: Connectors and other items in the setup 
Repeated baseline trials were run until repeatable pressure profiles were recorded. This 
was done in order to determine the residual pressure drop in the system. Details on the residual 
pressure trials are provided in Section 3.4. Poiseuille’s equation [Eq. (1), Section 2.8] was used 
to predict the theoretical pressure reading at the transducer by determining the losses across the 









various components [e.g., connectors and tubing] in the setup. Sample calculations are shown in 
Appendices I & J. Table 1 shows the changes made to the experimental setup over the one year 
period of this project. 
Table 1: Changes made to the setup over one year period of this project 
Month Changes made Reason 
November 
2014 
Collection trough [Fig.12] installed Drop formation at the outlet created 




New data logger installed in Setup #1 Data logger sent to OMEGA for repair in 
December 2014 [but never returned]. New data 




Second setup [Setup #2] installed  To make twice as many runs, but they cannot 
be run separately because a single software 




Needle connector used instead of 
cannula for Setup #2 
Continuous leak from cannula connection. 
July 2015  
[3rd week] 
Caulk lining and super glue coating 
on transducer connector for Setup #2 





Pump, PTFE tubes and reservoir 
exchanged between Setups #1 & #2 
Process of assessing differences between the 
two setups. Longer tubes in Setup #2 and 




Needle connector used instead of 
cannula for Setup #1 





3.3 Experimental Setup Validation 
In order to validate the experimental setups, experiments were conducted to see if the 
setups were able to produce pressures close to the clinically relevant range of 15 – 20 mm of Hg. 
One of the objectives of this research was to be able to run experiments simulating flow through 
an annulus. However, since it was difficult to know the amount [and eliminate the effects] of 
annulus eccentricity, the benchmarking was first done using some experiments with flow through 
a circular flow passage [tube] of set diameter and length that would yield nominal pressures 
close to physiologic IOP [around 15 mm Hg]. Since the differential pressure measured at the 
transducer would be affected by flow through the connections and tubing downstream, 
theoretical calculations were performed in order to determine the losses in the tubing between the 
three-way valve and the outlet immersed in the trough [Fig. 14]. The calculations showed that, if 
fluid flows at 2.5 µl/min through an 8 mm long BGI-like tube of internal diameter 50 microns, 
the observed pressure would be around 15 mm Hg. However, due to restrictions in the 
experimental setup, the trials had to be conducted using a 35 mm long tube instead of 8 mm, 
reasons for which are explained in detail later in this section [refer to Appendix I for theoretical 
calculations for 35 mm long tube]. 
It was difficult to find a tube with small inner diameter [50 microns] from conventional 
tubing manufacturers. However, gas chromatography tubing manufacturers suggested the use of 
PEEKsil tubes [31]. PEEKsil tubes [Figs. 15 and 16] are polymer-sheathed fused silica tubing, 
where the polymer is polyether ether ketone [PEEK]. These tubes are robust, inert to the fluid 
flowing through the tubes, and have smooth wall surfaces with precise inner diameters [± 5 
microns].  
The PEEKsil tubes had to be cut using a special ceramic column cutter [32] [Fig. 17]. 
The resulting cut could be rough, and it was crucial that the ends be checked for burrs and loose 
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silica fragments using a microscope [Figs. 15 and 16]. Care was taken to make sure that the inner 
linings of the tubes were not damaged in the process. For each test run, a tube was connected to a 
25 G syringe needle using super glue as shown in Fig. 18. However, there were problems 
because of the glue flowing into the needle and blocking the entrance to the tube. This problem 
occurred due to capillary effects between the tube and needle. This drawback led to inserting a 
longer tube [about 33 – 35 mm] into the needle so that there was no glue blockage at the entrance 
of the tube [refer to Table I.1.1 in Appendix I]. Since the length was more than the length of the 
needle, the super glue did not reach the entrance of the tube. 
The use of a 35 mm long tube resulted in a higher theoretical pressure of about 67 mm 
Hg [~ 4 times that of an 8 mm long tube]. This calculation did not consider tolerance factors for 
the inner diameter of the tube or pump flow rate. The tubes have an inner diameter of 50 ± 4 
microns. But even a one micron change in inner diameter would result in a huge change [about 5 
– 10 mm Hg, depending on the tube size] in the pressure calculation [see Appendix J]. Table 2 
lists the theoretical pressure range and the time-averaged pressures for each of the tube flow 
trials performed to validate both of the setups. For each trial, an average pressure was computed 
using the data points between a specific time frame when the pressure stabilized, say 3000 < t < 
7500 seconds, and the average of these time-averaged means is listed in Table 2.  
Table 2: Theoretical and experimental data for tube flow validation trials 
# of 
trials 

















7 2.5 ± 0.125 50 ± 4 35 101.5 ± 3.2 48.2 – 103.2 
5 2.5 ± 0.125 75 ± 4 35 15.0 ± 0.4 9.2 – 16.8 





Figure 15: 50 μm ID PEEKsil tube under the microscope 
[40X Magnification]  
 
Figure 16: Cross-sectional view 




Figure 17: Ceramic column cutter [reproduced from Ref. 29] 
 
 
Figure 18: 25 Gauge needle with PEEKsil tube of inner diameter 50 microns 
The pump flow rate has a tolerance of ±5% of the set point. This amounts to a variation 
of ±0.125 µl/min if the set point were 2.5 µl/min, and a variation of ±0.0625 µl/min if the set 
point were 1.25 µl/min. The theoretical calculations were done accounting for both of these 
variations. The resulting expected [theoretical] pressure range was 48 – 103 mm Hg. Table 3 
PEEKsil tube 
25 G Syringe 
Needle 
33 – 35 mm  
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shows how the individual components contributed to produce this pressure range. One can note 
that the possible variation of measured height, of about ±0.5 mm of water, has also been 
incorporated. Figure 19 shows a schematic representation of the different sections in the setup 
and the head loss in each section. As can be seen, only two loss sources, friction in the PEEKsil 
tubing and elevation change, are critical. The other sources are less than 0.01% of these two 
sources. 
 
Figure 19: Schematic representation of the connections and losses for flow through the critical 
parts of the setup for tubular flow 
The experiments were conducted with a 35 mm long tube [outer diameter = 0.22 mm, 
inner diameter = 0.05 mm] inserted in a 25 gauge syringe needle [inner diameter = 0.26 mm]. 
Figures 20 and 21 show the results from these experiments, and it can be seen that the pressures 
level off between 95 – 110 mm Hg. The experimental setup yielded results close to the 
maximum of the range of predicted theoretical pressures, and the time averages varied by about 
± 3.2 mm Hg between different trials showing reproducibility. 
It can also be seen in Fig. 20 that the pressures start off higher or lower and stabilize over 
time. The reason for the higher starting pressures in the data plot is because the setup was run at 
a higher flow rate [about 55 μl/min for 15 to 20 minutes] to remove any air bubbles in the setup 
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before actual data was recorded [Fig. 20]. Figure 21 shows a magnified portion of Fig. 20 when 
the pressures have settled down. Some trials were performed immediately after a previous trial 
without having the need to stop the pump; hence there was no need to run the setup at a higher 
flow rate to prime the setup and/or remove air bubbles. Therefore, when the needle–tube sample 
was replaced without shutting down the pump, the pressures initially dropped and gradually 
increased over time. This is the reason that some of the plot lines in Fig. 20 start at lower 
pressures.  
Table 3: Theoretical pressure range for 50 micron inner diameter tubing, flow rate of 2.5 
µl/min [from Appendix I] 
Section of the tube connection Theoretical Pressure Change 
(mm Hg) 
Lower limit Upper Limit 
Frictional loss in tube connecting three-way valve and 
needle hub [Section A of Fig. 19] 
1.16x10-4 1.28x10-4 
Sudden expansion in needle hub [Section B of Fig. 19] 4.56x10-11 5.57x10-11 
Frictional loss in conical needle hub [Section B of Fig. 19] 3.64x10-7 4.02x10-7 
Contraction loss in needle hub [Section B of Fig. 19] 1.27x10-12 1.55x10-12 
Contraction loss – Re-entry to needle [Section B of Fig.19] 1.12x10-3 2.59x10-3 
Frictional loss in silica tubes [Section C of Fig. 19] 49.96 104.87 
Change in elevation [from Sections A to C, exit of Fig. 19] - 1.73 - 1.65 





Figure 20: Pressure variations for trials with 50 micron inner diameter tubing at a flow rate of 2.5 
µl/min [Dates run: July 29 – 30, 2015] 
 




However, since the pressures observed in this range were not near the clinical range of 15 
– 20 mm Hg, another set of trials was run with tubing having a bigger inner diameter of 75 
microns [Fig. 22]. The same approach was used to determine the theoretical pressure range, 
considering the tolerance of the tubing diameter [±4 microns] and flow sensor [±5% of set point]. 
The resulting theoretical pressure range for a 35 mm long tube with inner diameter of 75 microns 
was 9 – 17 mm Hg [refer to Table 4 for pressure drop break down]. Again, only the frictional 
and elevation losses contributed significantly to the theoretical results. Experiments were run 
with the above configuration, and Fig. 22 shows the pressure variation for these trials. All data 
points beyond a time stamp of 1000 seconds were within a pressure range of 14 – 15 mm Hg 
with an average of 15 ± 0.4 mm Hg. The trials were conducted at 2.5 µl/min for a period of two 
hours using different tube samples. All samples were cut from a two meter long tube, and the cut 
edges were checked under the microscope to make sure that the edges were smooth [as seen in 
Figs. 15 and 16]. This was done to ensure repeatability of the trials [refer to Fig. 22]. Figure 23 
shows a magnified section of Fig. 22.  
Table 4: Theoretical pressure range for 75 micron inner diameter tubing, flow rate of 2.5 
µl/min [from Appendix I] 
Section of the tube connection Theoretical Pressure Change 
(mm Hg) 
Lower limit Upper Limit 
Frictional loss in tube connecting three-way valve and 
needle hub [Section A of Fig. 19] 
1.16x10-4 1.28x10-4 
Sudden expansion in needle hub [Section B of Fig. 19] 4.56x10-11 5.57x10-11 
Frictional loss in conical needle hub [Section B of Fig. 19] 3.64x10-7 4.02x10-7 
Contraction loss in needle hub [Section B of Fig. 19] 1.27x10-12 1.55x10-12 
Contraction loss – Re-entry to needle [Section B of Fig.19] 2.44x10-4 4.56x10-4 
Frictional loss in silica tubes [Section C of Fig. 19] 10.91 18.48 
Change in elevation [from Sections A to C, exit of Fig. 19] - 1.73 - 1.65 





Figure 22: Pressure variations for trials with 75 micron inner diameter tubing and flow rate of 2.5 
µl/min [Dates run: July 30 – 31, 2015] 
 




The data collected from both setups were compared for the 75 micron tube trials. The 
time-averaged data from Setup #1 [15.4 ± 0.1 mm Hg] was higher than that for Setup #2 [14.8 ± 
0.2 mm Hg]. The difference in the averages is around 0.8 mm of Hg [or 4%] and indicates that 
the setups produce different pressure data. The difference between the setups could be deemed 
negligible considering the clinical application that these setups will be used to simulate. This 
minor gap in average pressure could be because of the differences in the arrangement of the 
setups. For example, Setup #2 has longer connecting tubes than Setup #1, which could explain 
the higher observed pressures in Setup #1 than in Setup #2. However, further work needs to be 
done to make both the setups identical [same length tubes, better connectors, etc.,] thereby 
eliminating the difference in pressure measurement between the setups. 
The results from the 75 micron tubing trials match the clinical pressure range of interest. 
In order to check if the observed pressure would reduce by half if the flow rate were halved, 
more trials were run at 1.25 µl/min with the rest of the configuration remaining the same [75 μm 
diameter tubes]. Theoretical calculations predicted that the observed pressures would be in the 
range of 3.72 – 7.59 mm Hg [refer to Table 5 for pressure drop break down]. Figure 24 shows 
the pressure curves from the different trials run at 1.25 µl/min. Figure 25 shows a magnified 
section of Fig. 24. From Table 5, it can be seen that the elevation and frictional losses are the 
major contributors.  
From the pressure curves of Figs. 24 and 25, it can be noted that the observed stabilized 
pressures had an average of 8.4 ± 0.4 mm Hg, higher than the predicted theoretical range. The 
reason that the observed pressure readings were higher than the predicted theoretical range may 
be because the difference in elevation between the center of the transducer and the outlet was not 
accurately measured and had an error of about ± 0.5 mm of water. This translates to about ± 0.07 
mm Hg. Also, the transducer’s measurement could vary by ± 0.1 mm Hg.  
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Table 5: Theoretical pressure range for 75 micron inner diameter tubing, flow rate of 1.25 
µl/min 
Section of the tube connection Theoretical Pressure Change 
(mm Hg) 
Lower limit Upper Limit 
Frictional loss in tube connecting three-way valve and 
needle hub [Section A of Fig. 19] 
5.78x10-5 6.39x10-5 
Sudden expansion in needle hub [Section B of Fig. 19] 1.14x10-11 1.39x10-11 
Frictional loss in conical needle hub [Section B of Fig. 19] 1.82x10-7 2.01x10-7 
Contraction loss in needle hub [Section B of Fig. 19] 3.16x10-13 3.86x10-13 
Contraction loss – Re-entry to needle [Section B of Fig.19] 6.09x10-5 1.14x10-4 
Frictional loss in silica tubes [Section C of Fig. 19] 5.45 9.24 
Change in elevation [from Sections A to C, exit of Fig. 19] - 1.73 - 1.65 
Total 3.72 7.59 
 
 
Figure 24: Pressure variations for trials with 75 micron inner diameter tubing at a flow rate of 





Figure 25: Magnified section of Figure 24 for time ≥ 1000s 
 
The next phase of benchmarking was to run trials with inserts inside the tubes in order to 
determine the level of consistency [experimental data matching predicted theoretical range] for 
annular flow readings. A 15 mm long piece of 29 gauge steel wire [average diameter of 0.270 ± 
0.005 mm] was inserted in a 23 gauge syringe needle [inner diameter of 0.340 ± 0.005 mm]. The 
outer diameter of the 29 gauge wire and inner diameter of the 23 gauge syringe needle were 
measured using a stage micrometer under a 40X magnification microscope [Fig. 26]. If the flow 
rate were set at 10 µl/min, the annulus effect should produce a theoretical pressure range of 0.13 
– 3.23 mm Hg. This range was calculated based on the tolerances in the diameters of both the 
wire and needle, and elevation. The lower limit [0.13 mm Hg] of the resulting range was 
calculated using the biggest needle diameter [0.345 mm], smallest wire diameter [0.265 mm] and 
lowest flow rate [9.5 µl/min]; and vice versa [0.335 mm, 0.275 mm, 10.5 µl/min] for the upper 




Figure 26: Magnified view of 23 gauge syringe needle 
As in the previous calculations, only friction and elevation were significant. Figure 27 
shows a schematic of the connections and the possible losses in each section. Experiments were 
conducted with this configuration, and Fig. 28 shows the measured pressure variations. One can 
see that there are no high pressures at early times and throughout the period of the trial as shown 
in Fig. 28 as were seen in Figs. 20, 22 and 24. This is because the effective cross-sectional area 
for flow was higher for annular flow validation trials as compared with those of the 50 and 75 
micron diameter tubing trials. The flow rate at which Fig. 28’s experiments were conducted [10 
µl/min] was a much higher rate than the nominal physiological flow rate of 2.5 µl/min. The 
experiments were performed at a higher flow rate because the theoretical calculations predicted 




Figure 27: Schematic representation of the connections and losses for flow through the critical 
parts of the setup for annular flow 
Table 6: Theoretical pressure range for flow through annulus, flow rate of 10 µl/min 
Section of the tube connection Theoretical Pressure 
Change  (mm Hg) 
Lower limit Upper Limit 
Frictional loss in tube connecting three-way valve and catheter 
hub [Section A of Fig. 27] 
4.62x10-4 5.11x10-4 
Sudden expansion in catheter hub [Section B of Fig. 27] 5.4x10-10 6.59x10-10 
Frictional loss in conical hub [Section B of Fig. 27] 1.3x10-6 1.43x10-6 
Contraction loss in conical hub [Section B of Fig. 27] 1.62x10-11 1.98x10-11 
Frictional loss in connecting tubes [Section C of Fig. 27] 1.06x10-4 1.17x10-4 
Frictional loss in needle due to wire insert [Section D of Fig. 27] 1.86 4.88 
Change in elevation [from Sections A to C, exit of Fig. 27] - 1.73 - 1.65 





Figure 28: Pressure variation for trials with 29 gauge wire in 23 gauge needle at a flow rate of 10 
µl/min [Dates run: August 12 – 13, 2015] 
 
3.4 Residual Pressure in Baerveldt Tubing  
It is very important to be able to produce repeatable results for a set of similar flow 
conditions. This repeatability helps to guarantee the setups’ reliability; and it helps to know that, 
when changes are made in the original setup, these changes cause the measured pressures. A 
formal baseline for flow through a Baerveldt tube without an insert had to be defined for the 
setups and repeated at least twice in order to ensure repeatability. The baseline trials were 
performed at two flow rates: 1.5 and 2.5 μl/min with no insert in the BGI tube. These trials were 
run for a period of 24 hours. Pressure data from the transducer and flow data from the pump 
were recorded and reviewed. Figures 29 and 30 show the pressure at the three-way valve for 
repeated baseline trials conducted at 1.5 and 2.5 μl/min, respectively. Setups 1 and 2 refer to the 
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two experimental setups, which are identical in terms of components and heights but have 
slightly different lengths of connecting tubes. The length of the PEEK tube connecting the 
reservoir to the pump and pump to the rest of the setup, was different for each setup. Refer to 
Appendix K for the experimental procedure followed to conduct all trials. Table 7 lists the 
theoretical pressures predicted for one of the residual pressure trials. It must be noted that the 
negative values for the upper and lower limit are due to the elevation difference between the 
outlet and transducer. It is not clear why the theoretical calculations would yield a negative 
pressure range when experimental data are all positive. The reason for the ambiguity is unclear: 
however, further study of the theoretical calculations might shed some light on the negative 
theoretical pressure range.  
Table 7: Theoretical pressure range for residual pressure trials, flow rate of 2.5 µl/min 
Section of the tube connection Theoretical Pressure Change 
(mm Hg) 
Lower limit Upper Limit 
Frictional loss in tube connecting three-way valve and 
cannula hub  
1.16x10-4 1.28x10-4 
Sudden expansion in cannula hub  3.7x10-11 4.52x10-11 
Frictional loss in cannula hub  3.24x10-7 3.58x10-7 
Contraction loss in cannula hub 1.01x10-12 1.24x10-12 
Contraction loss from cannula hub to tube 1.45x10-8 1.77x10-8 
Frictional loss in cannula tube 1.85x10-4 2.04x10-4 
Contraction loss from cannula tube to implant tube 5.98x10-7 2.74x10-6 
Frictional loss in implant tube 7.64x10-3 3.17x10-2 
Change in elevation  - 0.49 - 0.45 
Total -0.48 -0.42 
 
From Figs. 29 and 30, it is seen that there are residual losses within the setups, and that 
these losses are relatively constant [within ±0.5 mm Hg] for a set flow rate; and, as mentioned in 
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the OMEGA product brochure, the transducer measures pressure with a variation of ± 0.1 mm 
Hg.  
When trials were run at 2.5 and 1.5 μl/min, the corresponding pressure readings at the 
three way valve were about 2.09 ± 0.19 mm of Hg [theoretical range was -0.48 to -0.42 mm Hg] 
and 1.47 ± 0.19 mm Hg [theoretical range was -0.46 to -0.44 mm Hg], respectively. The 
measured pressures include the elevation change between the center of the transducer and the 
Baerveldt tube outlet [as shown in Fig. 14].  
 
 






Figure 30: Pressure variations for residual pressure trials at 2.5 μl/min [Dates run: April 4 – 7, 
2015] 
3.5 Experimental Matrix 
The experimental matrix for the insert trials involved 4 parameters: flow rate, diameter, 
length and suture material, yielding a total of about 30 possible combinations. Since, the initial 
phase of this research was to develop a reliable experimental setup; it was decided to conduct 
trials which had clinical relevance [i.e., expected pressures within the range of 4 – 20 mm Hg]. 
Hence, the trials listed in Table 8 were conducted. 3-0 monofilament and 4-0 braided types of 
absorbable sutures were selected since using them resulted in pressures which fell within the 
range of clinical interest [15 – 20 mm Hg]. These trials would help to understand the pressure 
increase in the BGI tubing when different sutures were inserted. The effects of length, diameter 
and suture material on the pressure profile would help to determine a suitable material and 
dimensions to produce the required pressure drop. The suture diameters shown in Table 8 are 
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based on data found in suture manufacturing standards [27]. The matrix was put together 
assuming that at least 3 trials were run for each configuration. The results from these trials are 
discussed in detail in Chapter 4.  
Table 9 shows possible variations in the main parameters and the resulting variation in 
pressure with reference to the base condition [calculated assuming no variation]. It can be seen 
that the pressure can vary by 200 – 700% if either the tube inside diameter or insert outer 
diameter are varied. This is the main reason for having a theoretical pressure range instead of a 
single number. 






















3 ~ 24 
3-0 0.2 – 0.249 4 ± 0.5 2.5 ± 
0.125 
3 ~ 24 
3-0 0.2 – 0.249 8 ± 0.5 1.5 ± 
0.0625 
3 ~ 24 
2-0 0.3 – 0.339 4 ± 0.5 2.5 ± 
0.125 
4 ~ 24 





5 ~ 24 
3-0 0.2 – 0.249 8 ± 0.5 1.5 ± 
0.0625 
4 ~ 24 





4 ~ 24 
4-0 0.15 – 0.199 8 ± 0.5 2.5 ± 
0.125 
4 ~ 24 
TOTAL 30   
* Sources of diameter data are from Refs. 30 and 32. 
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If there is a variation in both, the insert’s outer diameter and tube’s inner diameter, the 
compounding effect on the theoretical pressure numbers are sizeable. Though flow rate and tube 
length do not seem to have much of an effect on the overall pressure, they do play a prime role 
when tubes of much smaller diameter [e.g., 50 – 100 microns] are considered. 
Table 9: Variation of theoretical pressure when major parameters change within 








Flow rate Tube 
length 
Tube inner diameter 
[mm] 
0.305 
0.305 + 0.025 
= 0.330 
0.305 0.305 0.305 
Insert outer diameter 
[mm] 
0.200 0.200 
0.200 + 0.049 
= 0.249 
0.200 0.200 
Flow rate  
[μl/min] 
2.5 2.5 2.5 
2.5 + 0.125 
= 2.625 
2.5 
Tube length  
[mm] 
8 8 8 8 




-0.20 -0.66 1.11 -0.06 -0.18 
% decrease in pressure 
with reference to base 
condition 
-- ~230% ~655% ~70% ~10% 
 
The calculated pressure includes a base height difference between the center of the transducer 
and BGI tube outlet. This is the reason why the calculated pressures are negative when this could 







Chapter 4: Results and Discussion – Short Term Trials 
In this chapter, the pressure profiles from the short term trials [discussed under Section 
3.5 and in Table 8] with suture inserts, both absorbable and non-absorbable, are presented and 
analyzed.  
4.1 Trials with 3-0 Prolene 
3-0 Prolene is a non-absorbable suture made of polypropylene whose nominal outer 
diameter is 0.2 mm [Table 8]. Sutures of lengths 4 and 8 mm were inserted into BGI tubing of 
inner diameter 0.305 mm; and experiments were conducted wherein the differential pressure 
between the three way valve and tube outlet [Fig. 14] was measured over a 24 hour time period 
for a set flow rate. The first three trials [Table 8] used a flow rate of 2.5 µl/min with an 8 mm 
suture insert [Fig. 31].  
The recorded pressures had an average of 2.84 ± 0.81 mm of Hg, and the theoretical 
prediction was 0.90 – 2.93 mm Hg. Two of the three trials had very similar pressure plots. In a 
clinical setting, a variation in pressure of about one to two mm of Hg is not considered 
significant [33]. However, while trying to characterize the pressure drop of an insert using these 
experimental setups, the difference between the trials does not help us to statistically analyze the 
data, even if the variation is about 6%.  
The pressures indicated on Fig. 31 naturally include the residual [Section 3.4], which is 
the pressure recorded when there is no suture in the tube. On average, from Section 3.4, residual 
pressure was found to be 2.09 ± 0.19 mm Hg. Thus, removing the residual pressure would cause 
Fig. 31 to range between 0.13 – 1.37 mm Hg. The individual curves in Fig. 31 probably differ 




Figure 31: Pressure variations for eight mm 3-0 Prolene insert; flow rate of 2.5 μl/min [Dates 
run: March 24 – 26, 2015] 
The next three trials [Table 8, row 2] were conducted with an insert of the same material 
as for Fig. 31’s trials, but with a shorter length of four mm [results shown in Fig. 32]. From 
Poiseuille’s flow equation [Eq. (1)], one can see that pressure drop is directly proportional to 
length. Hence, for the same set of parameters, if the insert length is halved, the pressure drop 
should also decrease by half. Unfortunately, it is not clear if the pressures measured [1.8 to 2.2 
mm Hg] are a result of the reduction in length of the insert or are just the residual pressure losses 
in the system [0 to 2.5 mm Hg, Fig. 30]. Theoretical calculations, considering that the sutures do 
not swell, showed that the pressures would be within a range of 0.54 – 2.08 mm Hg. However, it 
is evident that most of the Fig. 32 pressures are lower than what was measured when the insert’s 
length was 8 mm [Fig. 31]; so the trends are correct, but the values are not clearly half. Figure 32 
indicates similar spikes in the pressure profile as in Fig. 31, indicating the same possible issues 
with the way the suture was cut as for Fig. 31. Hence, in order to help clarify this issue, three 
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more trials were run where the insert length was set at eight mm, but the flow rate was reduced to 
1.5 µl/min [Fig. 33]. Though the reduction in flow rate was not exactly half [from 2.5 to 1.5 
µl/min], there should have been a proportional decrease [about 0.25 – 1 mm Hg] in measured 
pressure [from Eq. (2), discussed in Section 2.8].  
 
Figure 32: Pressure variations for four mm long 3-0 Prolene insert; flow rate of 2.5 μl/min [Dates 
run: April 7 – 9, 2015] 
Theoretical calculations predicted that, if the sutures do not swell, the pressures would be 
in the range of 0.22 – 1.29 mm Hg. From Fig. 33, it can be seen that the pressures measured for 
this trial are very similar to those of the previous trial [Fig. 32] for half of the insert length and 
higher flow rate. The ratio between the theoretical pressures for Figs. 32 and 33 should ideally be 
about 1 to 0.83; but the experimental results indicate that there is very little impact due to the 
reduction of flow rate and increase in length. It could be that the residual pressures dominate, and 
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the pressures created by the suture insert are relatively unimportant for sutures of this size and 
material. 
 
Figure 33: Pressure variations for eight mm long 3-0 Prolene insert; flow rate of 1.5 μl/min 
[Dates run: March 31 – April 2, 2015] 
4.2 Trials with 3-0 Monocryl 
3-0 Monocryl is a monofilament synthetic absorbable suture made from a copolymer of 
glycolide and epsilon-caprolactone [27]. This type of suture starts at the same size [200 microns, 
Table 8] as 3-0 prolene but expands, by about 100 microns in diameter, when it is submerged or 
comes in contact with a liquid [34]. The theoretical pressure, assuming no swelling of sutures, 
was found to be within the range of 0.9 – 2.93 mm Hg. However, if we calculate the theoretical 
pressures assuming that the sutures swelled, say by about 70 microns in diameter [creating an 
effective hydraulic diameter for fluid flow of around 100 microns], the resulting theoretical range 
is 2.01 – 5.75 mm Hg [suture diameter = 200 + 70 (because of swelling) = 270 microns, tube 
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inner diameter = 305 microns, flow rate = 2.5 μl/min]. This would mean that the measured 
pressure should be higher than what we observed for 3-0 Prolene, because, when the suture 
expands, the cross-sectional area for the fluid to flow through would be smaller [smaller annulus] 
for the Monocryl.  
The first set of four trials [Table 8, row 5] were run with an eight mm long insert at a 
flow rate of 2.5 µl/min. Figure 34 shows that the final pressure in the system at the end of the 24 
hour trial was between four and five mm of Hg for all trials. Also, the increasing trend of the 
curves suggests a gradual increase in pressure due to the swelling of the sutures inserted in the 
tubes. The increase in the pressure [3.59 ± 0.99 mm Hg] over 3-0 Prolene [2.84 ± 0.81 mm Hg] 
[Fig. 31] was reasonable considering the fact that these sutures swell based on the theoretical 
predictions for a suture of bigger diameter.  
  
Figure 34: Pressure variations for eight mm long 3-0 Monocryl insert; flow rate of 2.5 μl/min 
[Dates run: April 10 – 15, 2015] 
 
4 to 5 mm  
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In order to check for a drop in pressure when the flow rate is reduced, the next four trials 
were run with an 8 mm long insert at 1.5 µl/min. Unfortunately, the resulting pressure profiles 
did not have the same pressure trends [rate of increase], and hence the data obtained could not be 
used to verify the effect of reduction in flow rate on the pressure profile for the absorbable types 
of sutures. However, it might be inferred that the suture inserts were expanding at different rates 
because the flow rates were low and the inserts were probably not hydrolyzed evenly. Except for 
one trial on Fig. 35, the range of pressures was similar to that of Fig. 34.  
  
Figure 35: Pressure variations for eight mm long 3-0 Monocryl insert; flow rate of 1.5 μl/min 
[Dates run: April 16 – 17, 2015] 
4.3 Trials with 3-0 Braided 
The 3-0 braided suture is a synthetic absorbable suture which is a copolymer of 90% 
glycolide and 10% L-Lactide, also called Polyglactin [25]. Strands of thin monofilaments are 
wound together to get the braided look [Fig. 9] [27]. Just as a piece of thread expands when it 
3.75 to 5.25 mm  
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comes in contact with water, each of the braided sutures strands swell. That is to say, when fluid 
is flowing over the suture, it will probably expand and block the whole tube. Therefore, the 
length used was four mm instead of eight mm and was run at 2.5 µl/min [Fig. 36].  
 
Figure 36: Pressure variations for four mm long 3-0 Polyglactin braided insert; flow rate of 2.5 
μl/min [Dates run: February 24 – March 3, 2015] 
Though the curves of Fig. 36 are very different from each other, these results help one 
understand that the pressure can steeply or slowly increase over time. It was later understood that 
the location of the sample cut from the suture spool could also affect the rate at which the suture 
expands. To clarify, the suture connected to the suture needle of the spool has an exterior 
coating. This coating holds the monofilaments together, so that the individual monofilaments 
don’t spread when doctors use them during surgery. The thickness of the coating reduces over 
the length of the entire spool [27]. This thickness change, in turn, affects the spreading rate of 
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suture samples that are taken from different locations along the length of the spool. The samples 
for all of the trials shown herein were taken closer to each other in the spool in an attempt to 
eliminate the effect of the coating holding the filaments together. It is also possible that edges of 
the braided sutures were separated or expanded, which could have in turn created a dense porous 
section for the fluid to flow through the implant tube leading to higher pressures. The individual 
strands, that are wound together to form the braided suture, could be of different diameters 
causing non-uniform swelling of the suture, thereby creating a cross-sectional flow area that is 
not constant throughout the flow path, resulting in higher pressures.  
4.4 Trials with 4-0 Braided 
The 4-0 braided suture is smaller in diameter than the 3-0 braided suture used in the trials 
of Fig. 36. The nominal diameter for a 4-0 braided suture is 0.15 mm as compared to 3-0 sutures 
which have a nominal diameter of 0.2 mm [Table 8]. As explained in Section 4.3, braided sutures 
tend to expand and partially block the tubes, resulting in porous flow volumes. The results from 
the trials for 3-0 braided lead to running some trials with 4-0 braided sutures, assuming that 4-0 
sutures might not block the tubes as much. The four trials were run with eight mm long inserts of 
4-0 braided sutures; at 2.5 µl/min. Figure 37 shows the pressure variation for the four trials that 
were conducted with this configuration. Three of the four trials showed responses very similar to 
each other, though the pressure did not rise to the levels seen for trials with 3-0 braided inserts in 
Fig. 36. This corroborates the assumption that the pressure profile observed for 4-0 braided 
inserts should be lower than that of 3-0 braided inserts as seen in Fig. 37. One of the four curves 
is different, possibly because the sample swelled inconsistently due to the coating on the suture 




Figure 37: Pressure variations for eight mm long 4-0 polyglactin braided insert; flow rate of 2.5 
μl/min [Dates run: April 20 – 22, 2015] 
When comparing the pressures from Fig. 37 [between 3 and 5 mm Hg] with those of the 
3-0 Prolene trials [2.84 ± 0.81 mm Hg] [Fig. 31], it can be deduced that the average pressures are 
more or less in the same range. However, the pressure trend is increasing for the 4-0 braided 
suture insert trials but constant for the 3-0 prolene suture insert trials. If a similar comparison is 
made between the 3-0 braided and 4-0 braided trials, one can see that the 3-0 braided sutures 
produced much higher pressures [5 – 80 mm Hg] than did the 4-0 braided suture inserts. The 
reason for this difference is because a 4-0 suture does not swell as much as a 3-0 suture since 
their diameters are different. As explained earlier in Section 4.3, the edges of the 3-0 braided 
sutures could have been separated, resulting in a dense porous cross-section for the fluid to flow 
through. Also, it could be that the number of strands of monofilaments woven together to create 
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the 4-0 braided sutures was lower than the number of filaments used to make the 3-0 braided 
sutures. In short, fewer strands provide lower resistance to flow and cause lower pressure spikes 
in the system. 
4.5 Trials with 2-0 Prolene 
From Section 4.1, it can be seen that non-absorbable sutures, like 3-0 Prolene, do not 
cause much of an effect on the pressure increase in the system. Hence, four trials were run with 
2-0 Prolene to see the pressure difference as compared to the trials run with 3-0 Prolene. The 
nominal diameter for 2-0 Prolene is 0.3 mm [Table 8] which gives a really small clearance/gap 
when inserted in a tube having an internal diameter of 0.305 mm. It was expected that the 
measured pressure with this larger insert would be considerably higher than what was observed 
with 3-0 Prolene. Trials were conducted with four mm long inserts, run at 2.5 µl/min. The 
theoretical pressure range for this case was 350.9 – 1011.6 mm Hg. Figure 38 shows the pressure 
variation for different trials with 2-0 Prolene inserted in the tube. The graph bolsters our 
expectation of increased pressure when an insert of 300 microns is put inside a 305 micron 
internal diameter tube. The reason that the recorded pressure readings were much lower than the 
theoretical values could have been the low pressure range of the pressure transducer [0 – 129.3 
mm Hg – refer to Appendix E for specifications]. The actual diameters of the inserts could have 
been a little smaller. Even 5 microns could cause a major pressure reduction of 125.6 mm Hg. 
Burrs along the edges of the sample might have triggered the difference in peak pressures 
observed in each trial. Also, the pressure profiles of these non-absorbable sutures seem to exhibit 
some characteristics of absorbable sutures in the way that the pressure increases over time. This 
could mean that there were fragments of the suture breaking off and clogging the small annulus 
flow path, thereby leading to increasing pressures; or these structures might have also swelled by 
a micron or so, even though they were not supposed to. Also, the tolerance in diameter [± 5 
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microns] considered for our theoretical calculation might not be correct for the specific sutures 
used herein, even though the average tolerance is supposed to be ± 5 microns. 
 
Figure 38: Pressure variations for four mm long 2-0 Prolene insert; flow rate of 2.5 μl/min [Dates 
run: May 13 – 15, 2015] 
4.6 Resistance to Flow 
Resistance is defined as ΔP/Q and compared for all of the trials [from Figs. 31 to 37]. 


















     (3) 
where, 
ΔP  Pressure drop [Pa or mm Hg] 
Q  Fluid flow rate [μl/min or m3/s] 
μ  Dynamic viscosity of fluid [Pa.s] 
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L  Length of insert in tube [m] 
r2  Inner radius of tube [m] 
r1   Outer radius of insert [m] 
The resistances for all of the trials [from Figs. 31 to 37] were averaged for each time 
instant and plotted in Figs. 39 and 40. The average of the three or four pressure plots recorded for 
each configuration was used to determine the average resistance to flow, which is shown in Figs. 
39 and 40. Figure 38’s data was not included in this plot because the observed pressures were 
much higher than the clinically relevant range [below 20 mm Hg]. There is not much change in 
the resistance to flow for 3-0 Prolene [polypropylene] because, when the fluid flows over the 
surface, there is probably hardly any change in the diameter of the insert.  
From Figure 39, for 3-0 Monocryl, one can see that, when the flow rate is almost halved, 
the resistance to flow increases proportionally for cases when the length of the suture remains the 
same. But the trends are similar because the rate of swelling is probably similar for both sets of 
trials [Figs. 34 and 35]. The reason for this trend is that the filaments get hydrolyzed and swell 
during continuous exposure to any fluid. As the flow rate decreases and pressure drop decreases, 
and the value of the resistance to flow increases. This can be seen in Fig. 39 where the resistance 
to flow for 3-0 Monocryl at 1.5 μl/min is higher than that for the trial at 2.5 μl/min.   
The 3-0 Polyglactin 910 suture [braided] curve in Fig. 39 has a different trend as 
compared to those of the other curves because [explained in detail under Section 4.3] these 
sutures swell much more than 3-0 Monocryl when they come in contact with fluids, creating a 
dense porous section for the fluid to flow through. The resistance to flow increases with time as 




Figure 39: Resistance to flow for various inserts, for 24 hour trials 
 
Figure 40: Magnified section of Figure 39 
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Figures 39 and 40 can be used to better understand the variation of resistance to flow 
among sutures when similar flow conditions are set. The findings from resistance to flow curves 
can be summarized as follows: 
 Prolene inserts [non-absorbable] have low but constant resistance to flow, since there is no 
change in the annular flow path [cross-section] over time because the sutures do not swell 
with continued exposure to water. 
 Monofilament Monocryl inserts [absorbable] swell over time and hence the resistance to flow 
increases by a small amount with time. Annular cross-sectional area decreases as the insert 
swells.  
 Braided Vicryl [Polyglactin 910] inserts [absorbable] also swell over time but may create a 
porous flow path for the fluid, increasing the amount of fluid coming in contact to the 
filaments, thereby dramatically increasing the overall resistance to flow. The 3-0 Polyglactin 
910 sutures have an increasing resistance to flow because the individual strands in the suture 
probably swell when they come in contact with fluid and form a dense porous flow area 
creating an increasing trend in the flow resistance.  
 For the same type of suture, when the length is reduced by half, it has been shown that the 
resistance to flow reduces by roughly half, provided that the flow rate remains approximately 
constant. This is clear from the RHS of Eq. (3). 
 Also, when the flow rate is reduced by half, the resistance to flow remains constant because 
the pressure drop reduces by a proportional amount. This can be clearly seen because the 
RHS of Eq. (3) depends only on geometric factors and viscosity, which are constant. 
However, this does not hold true for absorbable sutures because their dimensions [and 




Chapter 5: Long Term Trials 
5.1 Results from Long Term Flow Trials 
As mentioned previously [Sections 4.3 and 4.4], on extended exposure to fluids, 
absorbable sutures deteriorate by a process called hydrolysis [process where the fluid gradually 
penetrates the suture filaments, producing a breakdown of the suture’s polymer chain]. These 
sutures swell up and slowly begin to erode/deteriorate over time [7 – 10 days for plaingut 
sutures, 30 – 60 days for both Monocryl and Polyglactin] [27]. This would mean that, when a 
suture is inserted in a tube and fluid flows through, the suture would first swell, then gradually 
decrease in size, leading to a sharp initial increase in pressure which would gradually drop to the 
residual value over time. The plan was to run multiple long-term trials in order to evaluate this 
prediction. However, only one trial could be run in each of the two setups, with distilled water 
instead of balanced salt solution. However, a deterioration study external to the two setups was 
done to compare the effects of using a balanced salt solution [BSS] instead of distilled water 
[DW].  
For the long term trials in the two setups, eight mm long 3-0 Monocryl sutures were 
inserted in ten mm long implant tubes; and one trial was done using each setup for a period of 30 
– 45 days. Figures 41 and 42 show the variation in pressure for Setup #s 1 and 2 for the entire 
duration of each trial. It can be seen that the pressure fluctuated significantly for reasons 
unknown at that time. Possible reasons for these fluctuations were later discovered during the 
stagnant long term trials [Section 5.2]. From the suture manufacturer’s website and product 
catalog, it was understood that the sutures would lose almost 50% of their tensile strength within 




Figure 41: Pressure variations for 8 mm long 3-0 Monocryl insert; and flow rate of 2.5 µl/min 
[Setup #1] [Dates run: May 18 – June 29, 2015] 
 
Figure 42: Pressure variations for 8 mm long 3-0 Monocryl insert; and flow rate of 2.5 µl/min 




Ideally, this means that the pressures should have started to decrease within the four week 
period. This is because the synthetic absorbable sutures are hydrolyzed when they are exposed to 
fluid. Ideally, complete absorption of the sutures should take about 60 – 90 days [25, 36]. 
The pressure fluctuations, as shown in Figs. 41 and 42, could indicate that the suture 
inserts underwent swelling and deterioration over time. Since it took a long time [about 35 – 40 
days] for the pressures to drop to acceptable levels [below 20 mm Hg], it was assumed that this 
larger-than-expected time might be due to the use of DW. DW, being an inert solution with no 
salt or acid dissolved in it, does not simulate actual physiologic conditions and does not have a 
composition similar to that of aqueous humor. So the long term trials were stopped; and a 
different study was conducted on the dissolution profile of the absorbable sutures in two different 
fluids – DW and BSS [Section 5.2].  
As mentioned earlier, BSS is similar to aqueous humor [produced in the eye] in its 
composition; and it was hypothesized that the deterioration of the suture would be faster in BSS 
as compared to DW [36]. The salts and acid concentrations in BSS deteriorate the polymer 
chains holding the suture together [36]. As explained earlier, absorbable sutures usually first 
expand in size [diameter and length] by absorbing the fluid in which they are immersed and then 
start to erode/decrease in size [diameter and length] [34]. An absolute deduction about the 
pressure variation for long term flow trials cannot be made, since a sufficient number of trials 
was not conducted. However, with the data available, it can be said that the sutures might have 
become too large in diameter because the observed pressures reached levels [more than 30 mm 
Hg] that are not desirable in a clinical situation [where IOP has to be below 20 mm Hg]. It could 
be that those pressures might reduce to the clinically desired range if absorbable sutures of 
smaller diameter, say 4-0 Monocryl, were used to run further long term studies.  
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5.2 Results from Long Term BSS vs DW Trials 
Twelve samples of 3-0 monocryl sutures were cut from the spool. Six samples were 
placed in vials having about two milliliters of DW, and six were immersed in BSS. The vials 
were secured in small boxes [refer to Figs. 43 and 44]; and beginning on July 2, 2015, they were 
rocked by hand every day for about 15 – 20 minutes manually in order to include an effect of 
fluid flow over their surfaces. Though the manual rocking/shaking was not a close approximation 
to the flow of fluid over suture surfaces at a slow flow rate of 2.5 µl/min, the rocking did help to 
mimic the effect of fluid movement over the sutures in order to increase the deterioration rate. 
The plan was to let the suture samples be immersed in stagnant DW or BSS for at least 30 days 
and determine the time taken for the samples to deteriorate. One sample each for DW and BSS 
was pulled every week or so to study the variation in diameter and look for effects of 
deterioration. When each vial was removed from the stack, approximate measurements of the 
diameter were made, using a microscope with a micrometer scale, and recorded. The micrometer 
scale had 100 divisions, where each division denoted 0.01 mm. One vial each of DW and BSS 
was removed at the same time to help compare the dissolution profiles of both samples. Table 10 
shows the measurements made over time for all of the samples; and Fig. 45 plots the measured 
diameters as a function of time. 
  






Figure 44: Exterior of boxes having six vials each with DW or BSS 
 
Figure 45: Harvested suture diameters over time 
Figures 46 – 50 show the physical changes in the surfaces and textures of the sutures over 
time. From these figures, it can be seen that the deterioration of the samples immersed in BSS 
was much faster than that of the samples immersed in DW. The reason why the samples 
immersed in BSS had greater deterioration rates was because the polymer chains were broken 
down during hydrolysis [37]. 
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Table 10: Diameter measurements at different time intervals over the 40 day trial 
Date DW sample 
diameter (mm)  
± 0.01 mm 
BSS sample 
diameter (mm) 




0.2  0.2 Before immersing the samples. 
Day 4 
[7/6/2015] 
0.3 0.3 Swollen samples. 
Day 13 
[7/15/2015] 
0.28 – 0.3 0.27 Slight discoloration of BSS sample. DW 
sample was clear. [Fig. 46] 
Day 23 
[7/25/2015] 
0.25 – 0.28 0.27 – 0.3 Flaking on the surface for BSS sample. 
No flaking on DW sample. [Fig. 47] 
Day 30 
[8/1/2015] 
0.25 – 0.27 0.27 – 0.3 BSS sample broken into two pieces. 
Flakes all over surface. Disintegrated. DW 




0.26 0.25 – 0.26 BSS sample had lacerations all over the 
surface. Flakes on DW sample. [Fig. 49] 
Day 40 
[8/11/2015] 
0.26 0.25 Both samples showed signs of extensive 
flaking. DW sample had longer flakes as 
compared to BSS sample. [Fig. 50] 
 
The ionic solution (BSS) played a major role in accelerating the hydrolysis, and this did 
not happen in the case of DW. During hydrolysis, the fluid enters into the monofilaments of the 
suture, internally reacting with the polymer, slowly eroding the suture from inside [25]. From 
Fig. 46, which was taken 13 days from the start, the BSS sample had striations along the surface, 
and there were ‘glints’ in the suture suggesting fluid seepage into the monofilaments. This effect 
was not very prominent in the DW sample, though both samples had absorbed the respective 
fluids. The BSS sample was slightly discolored [yellowish] as compared to the DW sample. The 




Figure 46: After 13 days – BSS sample on the top, DW sample on the bottom 
From Fig. 47, taken after 23 days from the start of the trial, the BSS sample showed 
greater signs of deterioration, in the form of ‘flaking’ on the surface. The surface was full of 
small flakes that curled out. Also the internal part of the suture suggested more seepage of the 
BSS fluid. The DW sample showed no signs of flaking on the surface but had significant 
striations along the length of the suture. Both samples were clear when examined under the 
microscope. 
 
Figure 47: After 23 days – BSS sample with flakes on the top and DW sample on the bottom 
 
In Fig. 48, taken 30 days from the start day, it is clear that the BSS sample was tattered 
and had started to fall apart. Though no tensile strength tests were conducted, it seems clear that 









comprehend the reduction in strength while handling the sample. The DW sample showed very 
slight signs of flaking on the surface, but it had many striations along its length suggesting fluid 
seepage into the monofilaments.  
 
Figure 48: After 30 days – Deteriorating BSS sample on the top and DW sample on the bottom 
At the end of 36 days, Fig. 49 show that the BSS sample had flaking and breaks along the 
length similar to what was seen in Fig. 48. The DW sample was very clear but had straight 
lines/breaks all along the surface, and also cavities were visible on the inside of the suture, 
suggesting internal erosion.  
 
Figure 49: After 36 days – Deterioration is visible in both samples 
At 40 days, Fig. 50, one can see that both samples showed flaking on the surface. The 
flakes on the DW sample were longer in length when compared to those of the BSS sample. 







Flaking was denser on the BSS sample as compared with the DW sample, and both samples were 
slightly discolored. 
 
Figure 50: After 40 days – Flakes on both samples 
From Figs. 46 – 50, one can see the difference in deterioration rates for both samples, 
suggesting that the BSS reacts much faster with the suture, whereas the DW takes more time to 
react. This would be because the different salts present in the BSS help to hydrolyze and erode 
the suture faster. Hence, from the results of these tests, it would appear to be better to use BSS as 
the operating fluid for running experiments which involve biodegradable/absorbable materials, in 
order to more accurately simulate physiologic conditions and to get a clear understanding of the 
dissolution rates and pressure profiles of suture-like polymer inserts.  
However, there is one big problem when it comes to running trials with BSS instead of 
DW. The BSS is a breeding ground for bacteria/algae, and there would be growth of some sort in 
the bottle/container in which BSS was stored. Hence, care must be taken to ensure that the 
bottle/container is cleaned every two weeks and made sterile using an autoclave. In addition to 
this, an anti-bacterial solution can be added to BSS in order to reduce the rate of bacterial 
growth.  
Another way to check for dissolution rates of sutures in BSS would be to take several 





movement of fluid in the vials. This part of the study was begun on August 1, 2015; and, as of 
August 14, 2015, there were no significant changes in the measured diameters. However, there 
could be an effect, because of rocking the samples, on the samples that will be examined around 
30 days from the start of the trial. A simple baby seat rocker was being used to simulate constant 








Chapter 6: Conclusions and Recommendation for Future Study 
6.1 Conclusions 
The long term goal for this research is to help patients affected by glaucoma and who 
have to undergo surgical implantation of glaucoma drainage devices. Improving the initial 
effectiveness of BGI is not only a step to improve the device, but also to ensure safety and 
comfort for patients who need the device.  
The main objective of this project was to develop and validate two experimental 
apparatus to measure the pressure drop along a BGI tube, with and without inserts. These setups 
will be used in the future to further evaluate the pressure drop resulting from the use of inserts. 
The current study was focused on benchmarking the experimental setup for the IOP range of 15 
– 20 mm Hg. Repeated experiments were conducted with different configurations of inner tube 
diameter, insert diameter, length of insert and fluid flow rate, in order to produce pressure 
variations in the clinically relevant range. The experimental measurements of pressure drop for 
the benchmarking trials were compared with theoretical calculations. The theory predicted that 
the pressure could vary within a range because of the variation in manufactured tube and insert 
diameters, control and detection of flow rates [refer to Appendix L for data on flow variation], 
sample lengths and profiles of cut sample edges.  
The benchmarking trials with 75 micron inner diameter tubes helped to document that the 
setups produce results that are different by approximately 1 mm Hg for a 15 mm reading [about 
6% variation]. The results from the 75 micron inner diameter tube trials were only used to make 
this comparison because only these results were close to the clinically relevant pressure drop 
[between 5 – 20 mm Hg]. It is imperative that there be no difference between the setups in order 
to achieve complete reproducibility between the setups, but a difference of 1 -2 mm of Hg is not 
critical in terms of a clinical standpoint. Hence, before further trials are performed, it is 
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recommended to further characterize the difference between the setups and consider changes to 
the setups to reduce or eliminate any differences.  
The experimental data set for flow through 50 μm inner diameter tubes at 2.5 μl/min gave 
pressure drops ranging from 97 to 105 mm Hg [101.5 ± 3.2 mm Hg], and were close to the upper 
limit of the theoretical range of 48.2 – 103.2 mm Hg.  In the case of the trials conducted with 75 
μm inner diameter tubes and flow at 2.5 μl/min, the observed pressures of 14.5 – 15.8 mm Hg 
[15.0 ± 0.4 mm Hg] were within the 9.2 – 16.8 mm Hg theoretically predicted range. However, 
for the experiments conducted with the 75 μm diameter tubes at 1.25 μl/min flow rate, the 
observed pressures, 8.2 – 8.6 mm Hg [8.4 ± 0.2 mm Hg], were higher than the upper limit of the 
predicted pressure range of 3.7 – 7.6 mm Hg. Since the upper limit of the predicted pressure 
range and the lower limit of the observed pressures were close, there may have been other small 
factors such as room temperature, relative humidity, error in measuring the elevation difference 
between transducer and outlet, pressure transducer measurement error, and/or surface roughness 
of the tubes, which could have contributed to this minor difference.  
The annular flow benchmarking trials produced results [2.98 ± 0.32 mm Hg] that were 
within the theoretically predicted pressure range of 0.13 – 3.23 mm Hg, for a flow rate of 10 
μl/min. The lower limit of the theoretical range was calculated for a wire insert of diameter 265 
microns and a needle inner diameter of 345 microns at a flow rate of 9.5 μl/min. The upper limit 
of the theoretical range was calculated for a wire insert of diameter 275 microns and a needle 
inner diameter of 335 microns at a flow rate of 10.5 μl/min. The next most critical part of this 
research would be to benchmark the setup by simulating annular flow that would produce 
pressures in the clinically relevant pressure range of 15 to 20 mm Hg with flow rate of 2.5 
μl/min. Though the observed pressures for the annular flow benchmarking trials [2.98 ± 0.32 mm 
Hg] were lower than the clinically relevant pressure range [5 – 20 mm Hg], the results indicated 
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that the experimental setups can produce pressures within the predicted theoretical pressure 
range. Though the effects of eccentricity were not considered when calculating the theoretical 
pressures, it is noted that the effect of eccentricity is a major factor that would help understand 
the variation of pressure for annular flow.  
In an attempt to understand the pressure response of flow through tubes with suture 
inserts, trials were conducted using different types of sutures. The properties that were varied 
were: the suture being absorbable/non-absorbable, fluid flow rates of 1.5 and 2.5 μl/min, suture 
lengths of 4 and 8 mm, and suture diameters of 0.15, 0.2, and 0.3 mm. The results showed that 
the pressure profiles of tubes with absorbable suture inserts increased over time [3 – 5 mm Hg], 
probably because these sutures expanded when hydrolyzed. In contrast, the pressure profiles for 
tubes with non-absorbable suture inserts demonstrated a reasonably steady pressure [1.5 - 3 mm 
Hg]. A comparison of absorbable and non-absorbable suture data confirms that using absorbable 
sutures could result in a much higher pressure drop. This being said, it is evident that the two 
setups assembled for this thesis can be used to verify the pressure response of different types of 
inserts, when they are placed within tubes of dimensions similar to those of Baerveldt Implant 
tubes. 
For every suture insert trial, each type of suture offered a different resistance to fluid 
flow. For example, absorbable sutures appeared to swell over time and created an increasing 
pressure drop [3-0 Monocryl, 8 mm long, 2.5 μl/min – 3.59 ± 0.99 mm Hg; 3-0 VICRYL 
Braided, 4 mm long, 2.5 μl/min – 5.07 ± 2.66 mm Hg] as compared to non-absorbable sutures 
[3-0 Prolene, 8 mm long, 2.5 μl/min – 2.84 ± 0.81 mm Hg]. This led to a comparison of the 
different trials using a resistance to flow variation chart. From this chart, it can be seen that the 
non-absorbable sutures had a reasonably steady and constant resistance to flow [around 1.2 mm 
Hg/(μl/min)] as compared to absorbable sutures. Though a constant flow resistance is good, it 
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does not address the issue at hand, which is to maintain pressures of at least 5 mm Hg in real life 
situations. The achieved pressure drop was small [less than clinically relevant pressure range of 5 
– 20 mm Hg], and the insert would be permanently lodged in the BGI tubing. If a non-absorbable 
suture were used in the BGI tubing, it could lead to complications in the long run because it 
would not be biodegradable. When scar tissue grew over the implant, the suture could cause 
additional pressure drop issues. The scar tissue alone creates sufficient flow resistance to help 
maintain the IOP above 5 mm Hg, so having a non-biodegradable insert in the BGI tubes could 
create a larger increase in the IOP than desired. This could create discomfort for the patient and 
could cause more damage to the optic nerve than help, if the IOP increased beyond 20 mm Hg. 
Also, if the sutures were pushed out of the tubing and into the eye, that suture could cause 
irritation and discomfort for patients. All of these factors indicate that a biodegradable polymer 
[absorbable suture] is preferred because the polymer could deteriorate and dissolve, even if it 
became dislodged from the tubing. 
The long term trials, both using the experimental setups and using stagnant fluid in vials, 
helped understand the pressure response and degradation profile of absorbable sutures 
[specifically, Monocryl] over time. Monocryl sutures deteriorate when they hydrolyze and 
appear to undergo bulk internal erosion that might not be a suitable characteristic for glaucoma 
related applications. This is because the observed pressures are much higher [4 – 150 mm Hg] 
than the clinically relevant range. Also, when the sutures undergo bulk erosion, layers of the 
polymer flake and tend to “fall off”. This could in turn block the tubes and result in temporary 
spikes in IOP. It might be better if a different polymer could be identified for further studies.  
Another important finding is the effect of the type of fluid used to run these trials on the 
dissolution rate of the biodegradable sutures. Though DW and BSS are similar fluids, the small 
concentrations of salts and acids in BSS made the sutures deteriorate within 23 days as compared 
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to DW, where it took over 30 days for the sutures to deteriorate. These preliminary studies 
indicate that future experiments should be conducted using BSS in order to best mimic 
physiological conditions in the BGI.  
The results from this thesis have helped solidify the basic modelling of micro-fluid flow 
and validated the experimental setups that can be used to conduct further studies. In the long run, 
these setups can be used to test various degradable inserts that would help to improve the initial 
effectiveness of the BGI.  
6.2 Recommendations for Future Study 
Based upon the results made available from this research and the fact that the setups 
produced different results, there is a large scope for further studies. Some of these studies are 
described in the following. 
1. With the data available from the long term trials using stagnant DW with inserts in 2 ml 
vials, it would be beneficial if similar trials were performed for different types of 
absorbable sutures, probably for a number of samples, in order to get a statistically better 
data set for evaluation. For these trials, it would be best to induce continuous movement 
in order to simulate flow over the sutures similar to what might occur for sutures in BGI 
tubes. These trials have been initiated using a rocker/mixer, but have not been completed.  
2. A different polymer, other than the bulk eroding sutures used in this thesis, could be used 
to study the effects that erosion modes [surface vs. bulk] could have on the pressure 
profile. 
3. To confirm that the results from the experiments proposed in items (1) and (2) match 
physiological conditions, experiments should be conducted using BSS instead of DW. 
4. If long term experiments are conducted with BSS instead of DW, determine ways to 
eliminate bacterial growth in BSS. 
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5. Because the suture diameters are either 200 or 300 μm in diameter and there is nothing 
commercially available in between, trials should be conducted with tubes of smaller inner 
diameter using the standard/available suture sizes that would produce pressures in the 
clinically relevant range.  
6. Determine if pre-hydrating 200 μm diameter absorbable sutures for a considerable length 
of time [say a week] before conducting trials has positive effects on the observed 
pressures during long term trials, i.e., resulting in pressures being in the physiologic 
range. 
7. To make it easier to test tubes of desired lengths [8 to 10 mm], modify the experimental 
setup using better tube connections so that the head losses due to friction in the long 
connecting tubes and expansions can be eliminated and making sure that the setups 
produce identical results. For example, the use of connections that do not have abrupt 
changes in diameter, should help to eliminate losses due to expansion and contraction. 
Also, tubes of shorter length [to eliminate frictional losses] and smaller diameter [to 
eliminate losses due to sudden expansion or contraction] could be used to connect the 
major components of the setup.  
8. Conduct experiments by changing both the elevation of the reservoir and collection 
trough, to check for variations in the observed pressure readings. Ideally, when the 
elevation of the reservoir is increased, the pump should require less power to pump the 
fluid and vice versa. When the elevation of the collection trough is increased with respect 
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Appendix A: Medical Terminology 
To better understand the causes and difference between the various types of glaucoma, it 
is essential to define the medical terminology used in this thesis. Following are explanations of 
some medical terms used herein. 
Aqueous Humor 
Aqueous humor is a fluid, rich in nutrients and electrolytes, produced to nourish the cornea and 
the lens [38]. Figure A.1 shows the front of the eye, where aqueous humor forms, and the normal 
flow direction [2].  From Fig. A.1, it can be seen that aqueous humor is produced in the ciliary 
body behind the iris and flows over the iris, finally draining into the trabecular meshwork.  
 
Figure A.1: Formation of aqueous humor and normal flow [reproduced from Ref. 2] 
Anterior Chamber, Angle and Trabecular Meshwork 
The anterior chamber is the part of the eye behind the cornea and in front of the iris and lens 
[Fig. A.1]. The anterior chamber angle and trabecular meshwork are located where the cornea 





Magnified view of 




humor drains out of the eye through it. Any unusual flow restrictions within the meshwork could 
result in an increase in IOP causing damage to the optic nerve [5]. 
Bleb Size 
The hole that is surgically made in the eye in order to insert the implant tubing into the eye [5]. 
Choroid 
The choroid is the layer of blood vessels located between the sclera and the retina. They provide 
nourishment to the back area of the eye [Fig. A.2] [38]. 
 
Figure A.2: Anatomy of the eye [reproduced from Ref. 37] 
Ciliary Body 
The ciliary body [Fig. A.2] is the part of the eye between the iris and choroid. The main 
functions of the ciliary body are producing aqueous humor and holding the lens in place [38]. 
Conjunctival Scarring 
Formed as a result of the body’s natural healing process by creating scar tissue around an 







The clear part of the eye covering the iris and the pupil [Fig. A.2]. The cornea lets the light into 
the eye, permitting sight [38]. 
Hydrolysis 
A process where fluid gradually penetrates the individual filaments of a suture, instigating a 
breakdown of the suture’s polymer chains [25]. 
Hypotony 
This condition results when the IOP is very low, in the range 0 – 5 mm of Hg. Patients with BGI 
and other non-valved implants, which do not have added flow regulators, have a higher risk of 
their IOPs dropping below 5 mm of Hg right after the surgical implant procedure. Hypotony 
results in corneal decomposition, accelerated cataract formation and discomfort [5]. 
Intraocular Pressure 
Intraocular pressure is the fluid pressure in the eye. A healthy IOP is the result of the equilibrium 
between the amount of aqueous humor being produced within the eye and the physiologic 
outflow of the fluid from the eye. The nominal range of IOP is between 8 and 20 mm Hg. When 
the outflow of aqueous humor is impeded, the pressure inside the eye begins to increase in order 
to maintain a constant flow rate. The optic nerve, being the weakest area in the eye, is most 
vulnerable to damage due to this elevated pressure. Continuous increase of pressure and damage 
to the optic nerve can lead to permanent vision loss [1].  
Iris 
The iris is the colored part of the eye surrounding the pupil. This pigmented membrane lies 
between the cornea and the lens. The iris acts as a diaphragm to widen or narrow the pupil, 





The optic nerve carries the nerves impulses from photoreceptor cells in the retina to the visual 
cortex in the brain [Fig. A.2] [38]. 
Posterior Chamber  
The posterior chamber is the space filled with aqueous humor behind the iris and adjacent to the 
lens [Fig. A.2] [38].  
Retina 
The sensory membrane that lines the eye [Fig. A.2]. It receives images formed by the lens and 
converts them into signals that reach the brain by way of the optic nerve  [38]. 
Sclera 
The outer coating of the eyeball that forms the visible white of the eye and surrounds the optic 
nerve at the back of the eyeball [Fig. A.2] [38]. 
Trabecular Meshwork 
The area of tissue in the eye located around the base of the cornea, near the ciliary body [Fig. 
A.1]. It allows drainage of the aqueous humor from the eye via the anterior chamber [38]. Under 
normal conditions, its resistance to flow helps to maintain the IOP within the nominal 8 – 20 mm 
Hg range.  
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Appendix B: List of Components in Setup 
The two setups were comprised of many components. Listed below are the main items in 
each setup. See Figures 12 – 14 for pictures of the setups. 
Table B.1: Major components of Setup #1 
Description Make/Model Serial #/Part # Specifications 
Pump CorSolutions – 
PneuWaveMicroPump 
S/N: 20141231.3 
P/N: CS3900r5 – 1 CH 




Omega – PX429-2.5GV S/N: 419411 0 – 2.5 psi 
[±0.2 psi] 
Data Logger Omega – OM-CP-
VOLT101A-160MV 
S/N: P44261 4 readings per 
second – 1 reading 
per 24 hrs 
500 ml Glass 
Bottle 
Sigma Aldrich - 
CLS13955000 





 15 feet long 
Power Supply Hewlett Packard S/N: E3630A 10 V DC supply 
Tubing  BD Medical  IV Tubing – ID 0.5”, 
6” long 
PEEK Tubing CorSolutions  ID 0.05”, 1’ long 
Needle 
Connector 
BD Medical Part #: 305156 22 Gauge, 1 ¼” long 
Caulk    
Rubber 
Connector 
Cover for leads of 
multimeter 
 Approx. 4” long 








Table B.2: Major components of Setup #2 
Description Make/Model Serial #/Part # Specifications 
Pump CorSolutions – 
PneuWaveMicroPump 
S/N: 20140701.3 
KU Med P/N: 
227494 
0 – 50 μl/min 
[±5%] 
Pressure Transducer Omega – PX429-
2.5GV 
S/N: 419345 0 – 2.5 psi 
[±0.2 psi] 
Data Logger Omega – OM-CP-
VOLT101A-160MV 
S/N: P59725 4 readings per 
second – 1 reading 
for 24 hrs 
500 mL Glass Bottle Sigma Aldrich - 
CLS13955000 
 500 ml 




 15 feet long 
Power supply Hewlett Packard S/N: E3630A 10 V DC supply 
Tubing  BD Medical  IV Tubing – ID 0.5”, 
6” long 
PEEK Tubing CorSolutions  ID 0.05”, 1’ long 
Needle Connector BD Medical Part #: 305156 22 Gauge, 1 ¼” long 
Caulk    
Rubber Connector Cover for leads of 
multimeter 
 Approx. 4” long 








Table B.3 lists the other components utilized to measure, analyze and prepare suture 
samples used in the various trials. These items were either borrowed from within the department 
or bought from vendors. 
Table B.3: Other components used in the experimental setup 
Description Make/Model Serial #/Part # Specifications 
Microscope Baush & Lomb  10X – 40X 
Magnification 
Baby Seat Rocker Redmon Rock On Car 
Seat Rocker 
4000 11.5” x 12” x 3”  
Stage Micrometer 
Scale 
OMAX Microscope Net CS-A36CALM1 1 mm width, having 
0.01 mm divisions 
Ruler   300 mm ruler  with 
1 mm divisions 
Superglue KrazyGlue  0.18 oz 
Glass Vials MHB VSC-1/12 1 Dram, pack of 12 
Medical Grade 
Connecting Tubes 
BD Medical  6 inch long 
0.5” inch diameter 
Medical Grade 
Tweezers 










Appendix C: PneuWave Pump Specifications 
The specifications below were taken from Corsolutions – PneuWave Micro Pump brochure [28] 
Flow specifications 
Flow rate range    0.1 to 50 μl/min 
Pressure range     0.01 to 14.5 psi 
Accuracy of flow measurement  0.5% of set point or 0.15% of full scale 
Repeatability below full scale  [flow]  0.01% of full scale 
Flow detection response time   40 msec 
Flow rate stability Down to 0.1% control volume [relative to fluid 
type, tubing and system set-up] 
Operating temperatures   10 to 50 ⁰C 
Fluid connector type    UNF ¼ - 28 flat bottom  
Flow sensor materials    Quartz Glass, PEEKTM, Teflon®, Tefzel® 
Flow sensor inner diameter   430 μm 
Flow sensor internal volume   5.1 μl 
Pressure specifications 
Pressure range with internal compressor 0 – 1 bar ± 0.15%  





Appendix D: PneuWave Pump Software User Manual 
The following procedure and pictures were developed by Ajay Ramani in order to help other 
graduate students working on this setup. To record the pump pressure data, follow the steps 
below. It would be better to review the entire procedure before performing it for the first time. 
Currently, a single computer is used to control both the pumps which means that trials running in 
both the setups must start and stop at the same time. In the future, if two independent computers 
controlled the pumps separately, then the trials in each setup could be performed for different 
periods of time.  
1. Start the computer connected to the pump. On the desktop, open the application with the 
name ‘CorSolutions PneuWave’ [Fig. D.1]. Make sure the pumps are switched on before 
opening the PneuWave software. 
 
Figure D.1: Desktop showing PneuWave pump software 
2. The software scans all of the ports and a dialog box pops up. Check/Select ‘COM3’ & 







Figure D.2: Select COM3 & COM4 
3. After selecting the pump, click ‘Finished’ [Fig. D.3]. 
 
Figure D.3: Select 'Finished' 
4. The next screen has the real time graphical input of each pump, the control mode they 
are in, and the set point [Fig. D.4]. 
Select COM3 for Pump1 
& COM4 for Pump2 
Click ‘Finished’ 





Figure D.4: Mode selection 
5. Select the required ‘Control Mode’, which is usually the ‘Flow’ mode. Set the required 
flow rate [e.g., 2.5 μl/min] and click ‘Set’. The pump takes 10 – 15 minutes to achieve 
the required flow rate [Fig. D.4].  
6. Once the pump has settled down and it is time to record data, select ‘Logging’ menu in 
the tool bar and select the rate as 1 second. The range available for rate of data capture is 
0.1 second, 0.5 second, 1 second, 5 seconds, and 10 seconds. Select ‘Enable’ under 
‘Logging’ menu to start recording data [Figs. D.5 and D.6].  
Select the Control 
Mode and Target 
Flow Rate Value, 




Figure D.5: Data logging rate options 
 
Figure D.6: To start data logging, select 'Enable' 
7. A prompt appears on the lower left corner of the window, displaying the location where 




Figure D.7: Data logging confirmation 
8. When the trial is done, click ‘Exit’ on the tool bar [upper left of the screen] to stop the 
data recording [Fig. D.5]. 
9. The data gets exported as a “*.csv” file and has columns which are labeled in Fig. D.8.  
 
Figure D. 8: Snapshot of output data file 
   
Control Mode: 
‘1’ for Pressure 
mode and ‘2’ 





Real time flow rate 
(µl/min) [measured 
by sensor] 
Real time Pressure 
















Appendix E: Omega Pressure Transducer Specifications 
The specifications below were reproduced from Omega’s Pressure transducer brochure [29]. 
Based on the target operational pressure range of the application, a transducer that would operate 
between 0 – 50 mm Hg [0 – 1 psi] was needed. However, in case the pressure in the setup should 
exceed this range, it should be possible to record and identify the reason because the selected 
transducer can measure up to 2.5 psi [160 mm Hg]. The specifications are:  
Model      PX429 – 2.5 GV  
Pressure range     0 – 2.5 psi 
Input      DC only; 5 – 10 V operating range 
Output range     0 – 100 mVdc 
Accuracy ± 0.08% BFS – Best Fit Straight line [combined 
non-linearity, hysteresis and non-repeatability] 
Zero Balance ± 0.5% FS typical, 1% max [1% typical, 2% max 
for 2.5 PSI and below] 
Span Setting ± 0.5% FS typical, 1% max [1% typical, 2% max 
for 2.5 PSI and below]. Calibrated in vertical 
direction with fitting down 
Long term stability ± 0.1% BFS typical [1 year] 




Appendix F: OMEGA Data Logging Software User Manual 
The following procedure and pictures were developed by Ajay Ramani in order to help other 
graduate students working on this setup. To record the transducer pressure data, follow steps 1 – 
12 on the following pages. The transducer and pump data logging cannot be started at the same 
time. The Pneuwave data logger is started first and then the OMEGA data logger. The OMEGA 
data logger uses the absolute clock time of the computer whereas the PneuWave data logger 
calculates time based on the instant the data logging is started. There is usually a gap of about 30 
seconds of recorded data between the two loggers. The method adopted to avoid any mismatch 
between the loggers is to set the pump at a higher flow rate and reduce it to the required level and 
use this peak in flow rate and pressure graph as a reference point while analyzing the data. 
1. Connect the Data Logger to the computer using the connector cable [Figs. F.1 and F.2]. 
 
Figure F.1: Data logger and connecting cable 
Connect the cable 




Figure F.2: Connected data logger 
2. On the desktop, open the application with the name ‘OM-CP Data Logger Software’ 
[Figs. F.3 and F.4]. 
 
Figure F.3: Desktop logo of data logging software 
Open the OM-CP 
Logger Software 
Cable connects to the 




Figure F.4: Prompt when user interface opens 
3. To start logging data, select the ‘Device’ tab, click on ‘Custom Start’ [Fig. F.5]. Always 
run the experiments using ‘Custom Start’ because the other ‘Starts’ require the data 
logger to be connected to the computer at all times, which drains the 3.5 V battery in a 
month.  
 





4. A dialog box pops up. Select the required start method [usually ‘Now’], stop method 
[usually ‘Manual’], and reading interval [usually 1 second]. Click ‘Start’ [Fig. F.6].  
 
Figure F.6: Select reading interval 
5. Once the Data Logger starts logging, the screen looks like Fig. F.7. 
 






6. When the trial is done, click the ‘Stop’ button on the tool bar [Fig. F.7]. Then, click 
‘Download’ to download the data from the last trial [Fig. F.8].  
 
Figure F.8: To download data, click 'Download' 
7. A dialog box pops up prompting the user to enter a file name. Click OK after entering a 
file name [Fig. F.9]. After the file gets downloaded, you will be able to see the 
tranducer’s recorded voltage readings plotted vs. time as shown in Fig. F.10. 
 
Figure F.9: Dialog box prompt 
Click ‘Download’ to 
download the data 
Click ‘OK’ after 




Figure F.10: Typical pressure data 
8. To export the data to an Excel file, click on ‘Export to Excel sheet’ button in the top right 
corner of the window [Fig. F.11]. 
 
Figure F.11: To export data file 
9. While the file is being exported, a prompt appears asking if a chart is required or not [Fig. 
F.12]. Usually not required.  
Voltage readings 
from transducer 





Figure F.12: Dialog box prompt 
10. An Excel file shows the data recorded by the Logger. Save the file to the required 
location [user’s choice] [Fig. F.13]. The exported data file includes information about the 
transducer device, date and time of data logging, and the real time voltage readings 
measured from the transducer. 
 
Figure F.13: Sample data log Excel file 
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11. Also save the Data Logger file when exiting the program [Fig. F.14] because the file can 
be used as a back up for the Excel file exported from the software. 
 
Figure F.14: Save the report every time 
12. Note that the program has to be closed and reopened every time the user switches 
between the two data loggers. The only difficulty that this causes is the fact that the trials 
running in both the setups cannot be stopped at the same time instant. Data is not lost 
because the software prompts to save any unsaved data file when the user attempts to 
close the software. If separate computers were used for each setup, an additional USB 




Appendix G: Data Logger Specifications 
The specifications below were taken from Omega’s Data Logger brochure [30]. Based on the 45 
day data logging requirements of the experiments, it was decided to use this type of data logger 
[long term data logging]. 
Model      OM-CP-VOLT 101A – 160 MV 
Voltage range     ± 160 mV 
Voltage resolution    5 μV 
Calibrated accuracy    ± 0.01% of reading 
Input impedance    > 1 MΩ 
Overload protection    ± 5V 
Input type     Differential 
Time accuracy     ± 1 minute/month 








Appendix H: Transducer Data Logger – Voltage to Pressure Conversion 
Equation 
From the Calibration Sheet provided for the transducer [29], a calibration curve was plotted and 
a linear equation fit was used to determine the conversion equation.  












Figure H.1: Output Voltage vs. Pressure calibration curve 
















Appendix I: Theoretical Pressure Calculation 
I.1 Flow through tube – Poiseuille’s Law 
From Eq. (1) [Section 2.8.1], Table I.1.1 was generated. For a set flow rate and length of 
tube, the inner radius of the tube is increased by a user-determined value, and the corresponding 
pressure drop is calculated automatically. The fluid flow rate [μl/min], inner radius of tube [mm] 
and tube length [mm] are the three values input by the user. The pressure drop is calculated using 
Eq. (1). Table I.1.1 was used to calculate that a tube of inner diameter 75 microns and length of 
35 mm would produce a pressure drop of ~ 15 mm. 




I.2 Flow through tube with insert – Modified Poiseuille’s Law 
From Eq. (2) [Section 2.8.2], Table I.2.1 was generated. This equation is used to predict 
the pressure drop across a tube having an insert in the tube, assuming that the tube and insert are 
concentric. The flow rate [μl/min], radii [mm] of tube and insert, and insert length [mm] are the 
only values input by the user. The modified Poiseuille’s law of Eq. (2) was used to calculate the 
pressure drop [refer to Fig. 8, in Section 2.8.2]. The highlighted portion in Table I.2.1 shows that 
the pressure drop for 10 μl/min annular flow through a 15 mm long tube with inner radius of 
0.1685 mm [or needle with diameter of 0.337 mm], having an insert with a radius of 0.1435 mm 
[or wire insert diameter of 0.287 mm], should be ~ 15 mm Hg.  





I.3 Flow through Annulus with Eccentricity – Annular Leakage Equation 
One of the most useful applications of the low-Reynolds number flow equation for hydraulic 
control systems is the annular leakage equation [20, 23, 24]. This is a general equation that can 
be applied when the following conditions are met: 
1. Flow is occurring within a circular tube having a solid round insert [Fig. I.3.1]. 
2. The center of the insert is not the center of the tube [off-center]. 
3. The flow is fully developed and at low Reynolds number [Re<<1]. 
4. Eccentricity ratio [ε = e / (r2 – r1)] is between 0 and 1. 
 
Figure I.3.1: Schematic of an annular leakage path [reproduced from Ref. 20] 








𝜀2) Δ𝑃          (I.1) 
where,  𝜀 =  
𝑒
𝑟2−𝑟1
             (I.2) 
It is very rare that the insert and tube are concentric. In most cases they are eccentric. The 
above equation could be used to account for the difference in pressure drop because of the 





Δ𝑃     (I.3) 
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For example, one could calculate the pressure drop for flow of water through a tube of 
diameter 0.337 mm with a concentric insert of 0.25 mm, length of insert in the tube being 10 
mm, and flow rate of 2.5 μl/min. From Eq. (I.3), the pressure drop is calculated to be 0.64 mm 
Hg, whereas the pressure drop calculated using Eq. (2) is 2.98 mm Hg. There is a 78% difference 
between the calculated theoretical pressures; and hence Eq. (I.1) cannot be used to calculate the 
effects of eccentricity on the pressure drop. Another form of the Poiseuille’s law must be 
identified that incorporates the effects of eccentricity and reduces to Eq. (2) when eccentricity is 
zero.  
From the derivation for the annular leakage equation, the pressure drop relation [when e 
= 0] was found to be [20]:  




          (I.4) 
where, 𝑟2 denotes the inner radius of the tube and 𝑟1 denotes the outer radius of the insert. To 
arrive at Eq. (I.3), Ref. [20] assumed that the gap between the tube and insert was small, i.e., 
(𝑟2 + 𝑟1 )  ≅  2 𝑟2, in Eq. (I.4); but this approximation was only applied to the term (𝑟2 + 𝑟1 ) in 
Eq. (I.4). To understand this effect with e=0, the ratio of the annular leakage equation to 
Poiseuille’s law (Eq. (2)) was studied for two cases. The first case analyzed the direct ratio of Eq. 
(I.3) to Eq. (2), yielding  
∆P calculated from Eq.  (I.3) when e=0















3       (I.5) 
 
The second case analyzed the direct ratio of Eq. (I.4) to Eq. (2), and slight simplification 
of the ratio yields Eq. (I.6).  
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∆P calculated from Eq.  (I.4) when e=0















3       (I.6) 
 
Analyzing the ratio between the pressure drops calculated using Eqs. (2) and (I.1) with 
zero eccentricity [Fig. I.3.2], it was determined that, when the radius of the insert approaches the 
inner radius of the tube, the pressure drop ratio goes to 1.0 for Eq. (I.5) and Eq. (I.6). Figure I.3.2 
shows a plot of Eq. (I.5) and Eq. (I.6) against the ratio of the radii. 
 
Figure I.3.2: Variation of the ratios between the pressure drops calculated from modified 
Poiseuille’s law and Annular Leakage equation when e = 0 
From Fig. I.3.2, it can be seen that when annular leakage equation’s assumption that the 
inner tube radius is approximately equal to the outer radius of the insert is used, at low ratios of 
the two radii, the annular leakage equation predicts a pressure drop, higher by at least 20% of the 
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pressure drop calculated by Eq. (2) alone. In contrast, if the radii are assumed to be different, 
then the pressure drop calculated from the annular leakage equation is less by almost 40% than 
the actual pressure drop. This indicates that the annular leakage equation is not the best equation 
to use when considering eccentricity because the equation cannot predict pressure drop at zero 
eccentricity correctly. No other reference equations were found to check the annular leakage 
equation for cases with eccentricity.    
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Appendix J: Theoretical Calculation – Benchmarking Experiments 
J.1 Flow through tube 
 This section shows the sample calculations for the head loss between the three-way valve 
and the fused silica tube outlet. Based on Dr. Kieweg’s and Ajay Ramani’s Excel file [Table 
J.1.2], the theoretical pressure ranges were calculated. Figure J.1.1 shows the different losses that 
are accounted for in the calculation spreadsheet [Table J.1.2] and the section in which they occur. 
In Table J.1.2, a user inputs the flow rate with tolerance [in μl/min], tube diameter with tolerance 
[m], tube length [m], height of the water in the collection trough [m], and elevation difference 
between the center of the transducer and the outlet [m]. The head losses from Sections A to C are 
calculated [Fig J.1.1] and displayed on the lower right side of Table J.1.2, along with total head 
loss. The lower and upper limits of the theoretical pressure range can be calculated by alternately 
entering ‘-1’ or ‘+1’ next to the tube diameter and flow rate variance sections in Table J.1.2.  
 
 
Figure J.1.1: Schematic of losses for the sections and connections of the needle-tube trials 
Table J.1.1 shows the how the contraction coefficient was calculated. The ratios of the 
diameters of the tube sections and the needle hub angle were used to calculate the contraction 
coefficient from Table J.1.1 [39]. The ratio d/D [or b/B] shown in Table J.1.1 denotes the ratio 




between the diameter of the IV tubing and diameter of the needle hub. The angle is measured at 
the expansion or the point where the tubes of the two diameters meet. From Figure J.1.1, we can 
see that the angle is 90⁰ for this case. The head loss for each section of Fig. J.1.1 was calculated 
as shown in Table J.1.2. The elevation change between the transducer and outlet was subtracted 
from the total loss since the center of the transducer was at a higher elevation than the outlet. 
Sample calculations in Section J.2 go over the manual calculation of all of the sections 
separately, providing a benchmark for the Excel calculator. 
Table J.1.1: Coefficients of Jet Contraction [reproduced from Ref. 38] 
 
The following are the assumptions made for these calculations because accurate measurement 
devices were not available at that time: 
1. The diameter where the luer lock meets the hub is 3.7 mm.  
2. The hub’s diameter reduces by 0.1 mm for every 1 mm of length.  
3. The length of Section B is 4 to 5 mm. 
4. For conical sections, where there is a smooth reduction in diameter, km values were found to 
be less than or equal to 0.02. km was assumed to be 0.02 since this would be the worst case 























































































































































































































































































































































































































































































































































































































J.2 Sample calculation of theoretical pressure drop for flow through tube 
These sample calculations were performed in order to confirm that the Excel sheets are 
computing values correctly. This calculation was done for Q = 2.5 μl/min, D = 75 μm. No 
variation in diameter or flow rate was considered. This calculation is for the same input 
parameters as in Table J.1.2. All formulas are reproduced from “Hydraulic Control Systems” by 
Noah D. Manring [20]. There might be a slight difference in the final value calculated manually 
because of rounding-off digits; but the closeness of the two results helps to confirm the accuracy 














J.3 Flow through tube with insert 
 This section shows the sample calculations for the head loss between the three-way valve 
and the fused silica tube outlet. Based on Dr. Kieweg’s and Ajay Ramani’s Excel file [Table 
J.3.1], the theoretical pressure ranges were calculated. Figure J.3.1 shows the sources of the 
different losses that are accounted for in the calculation spreadsheet [Table J.3.1] and the section 
in which these losses occur. 
 
Figure J.3.1: Schematic of losses along the connections - for flow through annulus 
The following are the assumptions made for these calculations because accurate measurement 
devices to measure length and angle were not available at that time. 
1. The diameter where the luer lock of the connecting tube meets the hub is 3.7 mm. 
2. The hub’s diameter reduces by 0.1 mm for every 1 mm of length.  
3. For conical sections, where there is a smooth reduction in diameter, km values were 
found to be less than or equal to 0.02. km was assumed to be 0.02 since this would be 
the worst case scenario and because the contraction in this section does not affect the 





































































































































































































































































































































































































































































































































































































J.4 Sample calculation of theoretical pressure drop for flow through annulus 
 These sample calculations were performed in order to confirm that the Excel sheets 
[Table J.3.1] are computing the values correctly. This calculation was done for Q = 10 μl/min, 
needle inner diameter = 357 μm, insert outer diameter = 272 mm. Variations in diameter and 
flow rate are not considered in this calculation but in Table J.3.1. The following gives a manual 
calculation of the pressure drop break down shown in Table J.3.1. All formulas are reproduced 














Appendix K: Experimental Procedure 
Goal 
The primary purpose of this experiment is to investigate the effect of introducing absorbable 
suture material inserts into Baerveldt Glaucoma Implant [BGI] tubes. 
Criteria for Success/Failure  
If the measured pressure lies between 15 to 30 mm of Hg when the flow rate is at 2.5 µl/min, 
then this experiment is considered a success. If not, the results would direct achievement of the 
pressure drop using alternate suture and tube sizes. 
Background 
Glaucoma is a condition that causes damage to the optic nerve due to buildup of pressure 
inside the eye. The increase in pressure, called intraocular pressure (IOP), damages the optic 
nerve resulting in poor eyesight and may lead to blindness after a significant period of time. 
When diagnosed with serious non-medicine treatable glaucoma, implants such as Baerveldt [Fig. 
K.1] or Ahmed [Fig. K.2] can be surgically inserted into a patient’s eyes. Regardless of the type 
of implant, its aim is to decrease the IOP to a lower limit of 5 mm Hg, by increasing the ease of 
outflow of fluid from the eye.  
 




Figure K.2: Ahmed Glaucoma Valve Implant [reproduced from Ref. 5] 
There is a possibility of low IOP in the case of BGI, due to low flow resistance 
immediately after surgery. There also have been instances where implants have failed due to 
healing and scarring over the surgical opening [bleb]. This will in turn lead to an increase in IOP 
which could be higher than the pre-surgery levels. 
To counter the low flow resistance immediately after surgery, an increase in the IOP 
could be achieved by creating a temporary blockage in the BGI tubes that would impede the flow 
until the scar tissue grows over the implant, creating the necessary back pressure to maintain the 
IOP above 5 mm Hg but below 20 mm Hg. This blockage does not have to be degradable, but 
biodegradable material was selected so that the normal flow can resume after 4 – 6 weeks.  
The pressure drop across the tube with the insert can be determined using modified 




































              (K.1) 
where 
µ   Dynamic viscosity of the fluid, m2/s 
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ΔL   Length of the tube, m 
Q   Flow rate, m3/s 
r2   Inner radius of the tube, m 
r1   Outer radius of the insert, m 
ΔP   Pressure drop across the tube, Pa 
Examples of calculations using Eq. (K.1) [or Eq. (2)] are in Appendices I and J. Alternatively, 
based on the pressure drop required, the length and/or diameter of the insert required could be 
calculated, keeping in mind that the insert length should be a maximum 8 mm because the length 
of the implant tubes used by surgeons while implanting BGIs is 10 mm.  
Equipment required for setup 
1. Connector tubing (dia. – 6 mm, length – 1 m) 
2. Baerveldt implant tubing (1) (dia. – 0.305 mm, length – 10 mm) 
3. Airtight container (1) – Dimensions: dia.: 60 mm, height: 120 mm, Volume 500 mL 
4. 20 gauge cannula (1) 
5. Pressure transducer (1) – Make: Omega; Model: PX429 – 2.5 G series [refer to App. C] 
6. PneuWave pump (1) – Make: Corsolutions, PneuWave series [refer to App. E] 
7. Luer locks (1)  
8. Absorbable sutures – Size 3-0, 4-0 [Monofilament & Braided – Absorbable & Non-
Absorbable] [refer to Table 1 in main text for details] 
9. Distilled water – 500 ml 
10. Medical grade scissors [6”], tweezers [6”] and super glue [0.34 oz] 
11. Microscope (1) – 40X magnification 
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12. Syringe needles of gauges 25, 27 and 30 
Experimental setup 
As explained in Chapter 3, the experimental setup is comprised of a PneuWave pump, 
medical grade connecting tubes, a three-way valve, an Omega pressure transducer, an Omega 
data logger, a 500 mL glass container, a gauge 20 cannula and a collection trough. Refer to 
Figure K.3 for a schematic of the experimental setup. Figure K.4 shows the actual benchtop 
experimental setup.  
 
Figure K.3: Schematic of experimental setup [reproduced from main text] 
 





1. Sterilize the airtight container, tubes and other connectors used in the setup. 
2. Fill the sterile airtight container with distiller water [DW] and seal the lid. Insert the 10 mm 
length of implant tubing [without the suture insert] into the 20 gage cannula as shown in Fig. 
K.5. Secure the implant tubing to the cannula using super glue. 
 
Figure K.5: Implant tube inserted in 20 gauge cannula 
3. Make sure that all tube connections and the three-way valve are connected as shown in Fig 
K.6. 
 
Figure K. 6: Tube connections and three-way valve orientation 









glue at this 
connection 
Implant tube Cannula 
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4. Prime the tubes with DW, by running the pump at a high flow rate – about 50 µl/min – for 
about 15 – 20 minutes, to help remove air bubbles from the setup. 
5. Perform a baseline trial run without a suture inserted in the implant tubing. A baseline trial is 
used to check for leaks in the setup and consistency in recorded pressure data at a set flow 
rate. 
6. Set the flow rate at 2.5 µl/min and measure the pressure using the data logger connected to 
the pressure transducer.  
7. Run the trial for a period of 2 – 3 hours and automatically record the variation of pressure 
both in the pump and transducer. The pump software [refer to Appendix D] can be used to 
record its data, and the data logger’s software [refer to Appendix F] can be used to record 
the transducer’s data. Normal data logging frequency used is 1 second.  
8. Once the experiment is completed, dispose of the tube and check to see if the bottle needs to 
be refilled [if water level is less than half]. Repeat steps 1 – 7, at least three times, for 
different samples of 20 gauge cannula in order to check for repeatability.  
9. If trials are being conducted without sutures, stop at this point and perform the trials again 
[steps 2, 3, 4, 6, 7, and 8]. If trials with sutures are being conducted, perform steps 10 – 12.  
10. To conduct trials with suture inserts, cut the suture [either absorbable or non-absorbable type] 
using the medical grade scissors to the required size [between 4 and 8 mm in length] and 
measure using a scale.  
11. Make sure that the cut edge is clean and without any burrs by examining the cut edges under 
the microscope. If a sample has burrs on the edge, dispose of it and cut another sample until a 
sample with clean edges is obtained. 
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12. Insert the suture into the implant tube [10 mm long] and then insert the implant tubing into 
the 20 gauge cannula. Secure the implant tubing in the cannula by applying superglue in the 
gap between the cannula and the implant tube [Fig. K. 5].  
13. Perform steps 3 and 4 to prime the setup, then begin the experiment [steps 10 – 12]; and 
record the pump and transducer data in the computer [follow steps shown in Apps. D and F].  
14. Conduct at least 3 trials [steps 10 – 12] for each configuration of diameter of the insert, 
length of the insert and flow rate.  
15. Compare the data plots for each configuration to the calculated theoretical pressure range. 
16. If trials are conducted for long durations, say 1 to 45 days, repeat steps 3, 4, and 10 – 12. 
Trials can be extended to longer time periods if the goal is to determine when the pressure 
drops to the acceptable range [15 – 20 mm Hg] or lower.  
17. Ensure that fresh samples of the sutures are used for each trial.  
NOTE: Both setups can be used to run similar trials simultaneously; or trials without sutures can 




Appendix L: Pump Flow Rate Variation  
It was observed that, although the set point specified for pump’s flow rate was 2.5 μl/min, 
the actual flow rate was varying with time owing to the flow control mechanism of the pump 
software. Hence, in order to determine if the actual flow rate of the pump was within 5% of the 
set point [App. C], the data for Fig. L.1 was taken. Figure L.1 shows the real-time flow rate 
variation at the pump when 3 trials with 75 micron [inner] diameter tubes were run at 2.5 μl/min 
in each setup.  
 




The average for all trials was close to 2.5 μl/min, but the variance was much higher for 
trial #1 of Setup #2. There is a slight variance in measured flow rate for all trials because the 
response time is short between the flow rate measurement sensor and the air compressor in the 
pump and results in sudden spikes or drops in the actual flow rate. The vendor claimed that this 
variation would be within 5% of the set point value, which was 2.5 μl/min for these trials. The 
reason for this variation could not be traced to its source; but some of the factors that might have 
contributed to this variation were possibly air bubbles in the tubing and/or a constant disturbance 
from an external source such as bumping into the setup or vibration from the compressor. Table 
L.1 shows the average flow rate and standard deviation for each trial.  
Table L.1: Average flow rate and standard deviation for 75 μm tube data shown in Fig. L.1 
Setup # Trial # 





1 2.5 ± 0.02 
2 2.5 ± 0.02 




1 2.51 ± 0.06 
2 2.51 ± 0.03 
3 2.5 ± 0.02 
 
From Table L.1, we can see that the variation in flow rate was between 0.8 – 2.4%, which 
is less than the 5% accuracy mentioned by the vendor’s product catalog [28] [refer to App. C].  
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For the trials with 50 micron tubes, it was observed that the flow rate error varied 
between 0.6 – 1.2%; and, like the data shown for 75 μm tubes, the flow rate error was less than 
5%. Table L.2 lists the average flow rate for each trial, and Fig. L.2 shows the variation in 
graphical form. It can be seen from Fig. L.2 that the variations were minimal. Therefore, it can 
be deduced that the vendor’s claims that the flow rate error variation is under ± 5% of the set 
point value is valid. 
Table L.2: Average flow rate and standard deviation for 50 micron trials shown in Fig. L.2 
Setup # Trial # 





1 2.5 ± 0.02 
2 2.5 ± 0.02 




1 2.52 ± 0.03 
2 2.51 ± 0.03 





Figure L.2: Flow rate variation vs. time for 50 micron inner diameter tube; set point flow rate of 
2.5 μl/min 
 
 
